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Abstract 
A ZnCl2-catalyzed diastereoselective Joullié–Ugi three-
component reaction from 2H-azirines, isocyanides and 
carboxylic acids has been established. The protocol allows 
the preparation of highly and diversely functionalized N-
acylaziridine-2-carboxamide derivatives in up to 82% 
isolated yields. Moreover, the applicability of N-
acylaziridines is demonstrated through a variety of 
transformations. 
Introduction 
Aziridines are not only important building blocks and 
synthetic intermediates but also present in a variety of 
biologically active natural (eg. azinomycins and 
mitomycins) and synthetic compounds exhibiting 
antibacterial, antimalarial, anticancer and enzyme 
inhibitory effects.1  
Due to the structural similarity to α- and β-amino acids, 
1H-aziridine-2-carboxylic acid (Azy) represents an 
exceptional interest among aziridines.2 This useful 
building block has prompted the preparation of di- and 
tripeptides by consecutive amino acid couplings towards 
the NH and carboxyl function of Azy.3 Following this 
strategy, a great number of N-acylaziridine-2-carboxylates 
and  
-carboxamides were synthesized and tested as cysteine 
protease inhibitors.4 
The known synthetic approaches towards N-
acylaziridine-2-carboxamides I are limited and almost 
exclusively proceed through the formation of aziridine 
carboxamide intermediate IV (Scheme 1). Most of the 
described methods start from protected amino acids serine 
and threonine II and transform the OH functionality to 
form the aziridine ring via multi-step processes.5,3b In 
addition, a careful choice of protective groups and peptide 
coupling techniques are required, while the achievable 
substitution pattern on the aziridine ring is very limited 
(R3=H; R4=H or Me; R5=H). Alternatively, aziridine-2-
carboxamide IV can also be obtained from compounds V 
and VI containing an active methylene group6 through 
Knoevenagel intermediate VII or from protected α-
iminoglyoxylic derivatives7 VIII. However, these 
synthetic strategies still suffer from low  overall yields and 
lack of diversity. It is notable, that fully-substituted N-
acylaziridine-2-carboxamides (R3, R4, R5≠H) have not 
been reported yet.  Therefore, the development of a rapid 
and straightforward approach to multisubstituted N-
acylaziridine-2-carboxamides still remains a synthetic 
challenge. 
 
Scheme 1. Synthetic protocols for N-acylaziridine-2-
carboxamides. 
An efficient opportunity for reducing the number of 
reaction steps and avoiding protective group strategies is 
represented by highly-convergent multicomponent 
reactions (MCRs).8 The isocyanide-based Ugi four-
component reaction is one of the most relevant MCRs, 
which allows the construction of complex α-aminoacyl 
amide peptidomimetics in a one-step operation.9 Although 
the classical Ugi reaction provides linear products, various 
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heterocycles (rarely aziridine)10, can also be accessed 
either through post-condensation reactions or by the 
application of bifunctional inputs.9,11 For example, 
utilization of cyclic imines in the three-component Joullié–
Ugi reaction12 (JU-3CR) affords diverse five-,13 six-13,14 or 
seven-membered13,15 N-acylated heterocycles. 
Here, we describe the first utilization of 2H-azirines in the 
JU-3CR, leading to heavily substituted N-acylaziridine-2-
carboxamides in a straightforward one-pot procedure. 
Results and Discussion 
Preliminary investigations were started by examining the 
reaction of racemic ethyl 3-methyl-2H-azirine-2-
carboxylate16a (1a) with  tert-butyl isocyanide (2a) and 
benzoic acid (3a) under the reported Joullié–Ugi 3CR 
conditions (MeOH, toluene; rt or reflux).14a,17 However, no 
conversion was observed. Gratifyingly, performing the 
model reaction in refluxing THF offered the target product 
in 8% isolated yield after two days (Table 1, Entry 1). 
Since Lewis acids could increase the reactivity of 
azirines,18 we tested several Lewis- and Brønsted acids as 
promoters in the model reaction (Table 1, Entries 2–18).  























(±)-1a 2a 3a (±)-5{1}  
Entry Catalyst  Yield (%)b  dr (trans:cis)c 
1d - 8e 93:7 
2 PTSA 0 - 
3 HClO4 0 - 
4 In(OTf)3 0 - 
5 Mg(OTf)2 0 - 
6 Dy(OTf)3 0 - 
7 InF3 0 - 
8 CuBr2 0 - 
9 CuCl2 0 - 
10 AlCl3 0 - 
11 SnCl2 12 92:8 
12 FeCl3 13 92:8 
13 In(OAc)3 16 88:12 
14 Zn(OAc)2 20 90:10 
15 ZnO 23 87:13 
16 InCl3 51 94:6 
17 ZnBr2 56 92:8 
18 ZnCl2 71 93:7 
19 ZnCl2
 f 61 93:7 
20 ZnCl2
 g 54 94:6 
aReaction conditions: 2H-azirine (0.25 mmol), tert-butyl isocyanide (1.1 
equiv.), benzoic acid (1.1 equiv.), anhydrous THF (0.5 mL), catalyst (25 
mol%), argon atmosphere, 55 °C, 6 h. bCombined yield of 4{1} and 5{1}. 
Determined by HPLC analysis. cThe diastereomeric ratio (dr) was 
determined by HPLC analysis. Both diastereomers were calibrated. d48 h, 
reflux. eIsolated yield. f10 mol% catalyst was used. g50 mol% catalyst was 
used. 
Most of the applied catalysts proved to be ineffective 
(Table 1, Entries 2–15), except InCl3 and ZnBr2 showing 
moderate catalytic activity (Table 1, Entries 16 and 17). In 
contrast, ZnCl2 was found to be a superior catalyst 
providing the desired N-acylaziridines 4{1} and 5{1} in 
71% combined HPLC yield. Applying both lower (10 
mol%) and higher (50 mol%) loadings of ZnCl2 resulted in 
decreased yields (Table 1, Entries 19 and 20). All reactions 
gave predominantly trans-aziridine 4{1} with high 
diastereoselectivity (from 87:13 to 94:6 trans:cis dr), but 
the amount of catalyst did not influence the stereochemical 
outcome. The stereochemistry of rac-4{1} and rac-5{1} 
diastereomers was determined by NOESY experiments 
(see Supporting Information).  
Next, we focused on exploring the effect of solvents, 
temperature and concentration (Table 2). The reaction was 
found to tolerate a wide range of media with no distinct 
changes in the dr (from 89:11 to 93:7; trans:cis). The 
developed JU-3CR is mostly favored in non-polar (toluene 
and 1,4-dioxane) and polar aprotic solvents (CHCl3, THF 
and MeCN). The only exception is DMF, which was not 
tolerated (Table 2, Entries 3–8). Of all solvents applied, 
THF was found to be the best solvent to form aziridine in 
72% combined HPLC yield. Additionally, we attempted to 
accelerate the reaction by using microwave irradiation 
(Table 2, Entries 9–11). By raising the reaction 
temperature (80–120 °C) a clear trend of decreased yields 
and dr was observed. On the other hand, by lowering the 
concentration of azirine (±)-1a, improvements in combined 
yields and diastereomeric ratios could be achieved (Table 
2, Entries 13 and 14). 
Table 2. Optimization of the reaction conditions.a 
 
Entry Solvent Temp. (°C) Yield (%)b dr b 
1 EtOH 55 12 91:9 
2 IPA 55 40 93:7 
3 MeCN 55 56 89:11 
4 DMF 55 0 - 
5 THF 55 72 93:7 
6 CHCl3 55 61 90:10 
7 1,4-Dioxane 55 64 92:8 
8 Toluene 55 57 91:9 
9 THF 80 c 64 94:6 
10 THF 100 c 58 91:9 
11 THF 120 c 55 88:12 
12 THF  d 55 68 91:9 
13 THF e 55 77 94:6 
14 THF
 f 55 81 96:4 
aReaction conditions: 2H-azirine (0.25 mmol), tert-butyl isocyanide (1.1 
equiv.), benzoic acid (1.1 equiv.), anhydrous solvent (0.5 mL), anhydrous 
ZnCl2 (25 mol%), argon atmosphere, 3 h. 
bCombined yield and dr were 
determined by HPLC analysis. cMW conditions: 30 min, 250 W. d0.25 mL 
anhydr. solvent was applied. e1 mL anhydr. solvent was applied. f2 mL 
anhydr. solvent was applied and 4 h reaction time was necessary for full 
conversion. 
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In further studies, we reacted racemic ethyl 3-methyl-
2H-azirine-2-carboxylate (1a) and tert-butyl isocyanide 
(2a) with varied carboxylic acids (3a–j) using the optimal 
reaction conditions (anhydr. ZnCl2, anhydr. THF, argon 
atmosphere, 55 °C, 4 h) (Table 3, Entries 1–10). Benzoic 
acids bearing electron donating (3-MeO, 4-OH) or 
electron-withdrawing (2-Cl) substituents afforded the 
desired products in moderate to good yields (Table 3, 
Entries 1–4). Good yields were obtained as well, when 
phenylacetic acid (3e) and 3,4,5-trimethoxycinnamic acid 
(3f) were reacated, providing 4{5} and 4{6} in 69% and 
60% yields, respectively (Table 3, Entries 5 and 6). 
Moreover, nicotinic acid, a heteroaromatic carboxylic-
acid, could also be subjected to the reaction (Table 3, 
Entry 7).  Gratifyingly, the reaction also tolerated aliphatic 
carboxylic acids such as acetic and chloroacetic acids 
giving good yields (Table 3, Entries 8 and 9). To our 
delight, utilization of the weakly nucleophilic 
trifluoroacetic acid smoothly afforded the desired N-
acylaziridine 4{10}  in 54% isolated yield, which 
demonstrates the robustness of the carboxylic acid scope. 
Table 3. Scope of isocyanides and carboxylic acids.a 
 
Entry 2  (R1) 3  (R2) 4 Yield (%)b drc 
1 2a  R1=t-Bu 3a  R2= Ph 4{1} 69 (78) 96:4 
2 2a  R1= t-Bu 3b  R2= 3-MeOC6H4 4{2} 72 (79) 95:5 
3 2a  R1= t-Bu 3c  R2= 4-HOC6H4 4{3} 56 (62) 93:7 
4 2a  R1= t-Bu 3d  R2= 2-ClC6H4 4{4} 61 (74) 94:6 
5 2a  R1= t-Bu 3e  R2= Bn 4{5} 69 (75) 94:6 
6 2a  R1= t-Bu 3f  R2=3,4,5-MeOC6H2CHCH 4{6} 60 (69) 95:5 
7 2a  R1= t-Bu 3g  R2= 3-pyridyl 4{7} 28 (38) >99 
8 2a  R1= t-Bu 3h  R2= Me 4{8} 75 (79) 95:5 
9 2a  R1= t-Bu 3i  R2= ClCH2 4{9} 55 (60) 94:6 
10 2a  R1= t-Bu 3j  R2= CF3 4{10} 54 (58) 97:3 
11 2b  R1= t-Octyl 3a  R2= Ph 4{11} 78 (82) 94:6 
12 2c  R1= c-Hex 3a  R2= Ph 4{12} 71 (75) 93:7 
13 2d  R1= Bn 3a  R2= Ph 4{13} 58 (60) 94:6 
14 2e  R1= 3,4,5-MeOC6H2 3a  R
2= Ph 4{14} 38 (40) 97:3 
15 2f  R1=4-NO2C6H4 3a  R
2= Ph 4{15} 60 (69) 97:3 
16 2b  R1= t-Octyl 3e  R2= Bn 4{16} 77 (80) 95:5 
17 2g  R1= n-Pentyl 3e  R2= Bn 4{17} 79 (82) 95:5 
18 2c  R1= c-Hex 3b  R2= Me 4{18} 68 (76) 96:4 
19 2c  R1= c-Hex 3e  R2= Bn 4{19} 60 (71) 93:7 
20 2c  R1= c-Hex 3k  R2= 2,4,6-Me C6H2 4{20} 80 (85) 96:4 
21 2c  R1= c-Hex 3l  R2= 3-FC6H4 4{21} 77 (86) 93:7 
22 2d  R1= Bn 3e  R2= Bn 4{22} 67 (69) 93:7 
23 2d  R1= Bn 3f  R2=3-MeOC6H4 4{23} 58 (60) 96:4 
24 2e  R1= 3,4,5-MeOC6H2 3b  R
2= Me 4{24} 22 (34) 99:1 
25 2e  R1= 3,4,5-MeOC6H2 3e  R
2=Bn 4{25} 36 (40) 97:3 
26 2e  R1= 3,4,5-MeOC6H2 3a  R
2= 4-CF3C6H4 4{26} 29 (36) 97:3 
27 2f  R1= 4-NO2C6H4 3c  R
2= ClCH2 4{27} 56 (62) 96:4 
28 2f  R1= 4-NO2C6H4 3l  R
2= 3-FC6H4 4{28} 28 (38) 96:4 
aReaction conditions: 2H-azirine (0.5 mmol), anhydrous THF (4 mL) isocyanide (1.1 equiv.), carboxylic acid (1.1 equiv.), anhydrous ZnCl2 (25 mol%), 
argon atmosphere, 55 °C, 4 h. bIsolated yield of the major trans diastereomer (NMR yield in parenthesis). NMR yield was determined by 1H-NMR with 
1,3,5-trimethoxybenzene as internal standard. ctrans/cis diastereomeric ratio (determined from crude reaction mixture by LC-MS)
Then, the scope of the reaction with respect to the 
isocyanide reagent was investigated using (±)-1a and 3a as 
coupling partners (Table 3, Entries 11–15). When aliphatic 
isocyanides 2b and 2c were applied, the reactions also 
proceeded smoothly leading to 4{11} and 4{12} in 78% 
and 71% yields. When benzylic 2d and aromatic 
isocyanides 2e and 2f were subjected to the reaction, lower 
yields were observed (Table 3, Entries 13–15, 38–60% 
yields). Interestingly, aromatic isocyanide 2f bearing the 
electron-withdrawing nitro group provided a better isolated 
yield (60%, Entry 15), than the more nucleophilic 3,4,5-
trimethoxyphenyl isocyanide 2e (38%, Entry 14). 
To evaluate the general performance of our method, we 
carried out further tests with other combinations of the 
isocyanide and carboxylic acid components (Table 3, 
Entries 16–28). The protocol allowed the use of a wide 
range of functional groups and furnished the corresponding 
N-acylaziridines 4 in up to 80% yields with high 
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diastereoselectivities (ranging from 93:7 to >99:1 trans:cis 
dr). As expected, only the isocyanide component affected 
the outcome of reactions. With benzyl and aliphatic 
isocyanides (Table 3, Entries 16–23) better isolated yields 
could be obtained in contrast to aromatic isocyanides 
(Table 3, Entries 24–28). 
To extend the applicability of the reaction, various 2H-
azirines16 1b–f were utilized under the optimized 
conditions (Table 4). For comparison, 2H-azirines 1b–f 
were reacted with tert-butyl isocyanide (2a) and benzoic 
acid (3a). As expected, azirine 1b gave the desired N-
acylaziridines 4{29–32} with high diastereomeric ratios, 
albeit in slightly lower yields compared to 
azirine 1a (Table 4, Entries 1–4). On the other hand, when 
fully-substituted 2H-azirine 1c was subjected to the 
reaction, significant decreases in diastereomeric ratios 
(58:42 to 64:36) were observed with the concomittant 
increase in reaction time (6 h) (Table 4, Entries 5–7). 
These phenemona are most probably due to steric 
repulsion between the corresponding isocyanide and the R3 
(methyl) substituent of azirine (Table 4, Entries 5–7). 
Products derived from tert-butyl and benzyl isocyanide 
were isolated as diastereomeric mixtures in 55% and 41% 
combined yields, while aziridine 4{34} could be obtained 
as a pure diastereoisomer. Surprisingly, introducing the 
sterically more demanding benzyl function at the C2 of 
azirine (substrate 1d) resulted in the inversion of 
stereochemical outcome of the reaction (42:58 dr) and 
provided cis aziridine 5{36} as major product (Table 4, 
Entry 8). We were pleased to find that phenyl-substituted 
2H-azirines 1e and 1f were also compatible with the 
developed JU-3CR method and furnished the 
corresponding trans N-acylaziridines 4{37–44} with 
excellent diastereoselectivities (>99%, Table 4, Entries 9–
16).
Table 4. Scope of 2H-azirines.a 
 








2a R4= t-Bu 3a R5=Ph 4{29} 61 74 94:6 
2 2c R4= c-Hex 3b R5= Me 4{30} 54  60 96:4 
3 2d R4= Bn 3e R5= Ph 4{31} 22  23 94:6 
4 2e R4= 3,4,5-MeOC6H2 3k R
5= 2,4,6-Me C6H2 4{32} 20  35 97:3 
        
5b 
 
2a R4= t-Bu 3a R5= Ph 4{33}+5{33}f 55h 39/21j 63:37 
6b 2c R4= c-Hex 3a R5= Ph 4{34} 31 38/25j 63:37 
7b 2d R4= Bn 3f R5= 3-MeOC6H4 4{35}+5{35}
f
 41h 27/19j 60:40 
        
8b 
 
2a R4= t-Bu 3a R5= Ph 4{36}, 5{36}g 17/23i 22/29j 42:58 
        
9 
 
2a R4= t-Bu 3a R5= Ph 4{37} 70  77 >99 
10 2a R4= t-Bu 3b R5= Me 4{38} 61  64 >99 
11 2c R4= c-Hex 3k R5=2,4,6-Me C6H2 4{39} 28  33 >99 
12 2e R4= 3,4,5-MeOC6H2 3e R
5= Bn 4{40} 43  45 >99 
        
13 
 
2a R4= t-Bu 3a R5= Ph 4{41} 67  71 >99 
14 2a R4= t-Bu 3b R5= Me 4{42} 62  70 >99 
15 2c R4= c-Hex 3k R5= 2,4,6-Me C6H2 4{43} 40  44 >99 
16 2e R4= 3,4,5-MeOC6H2 3e R
5= Bn 4{44} 51  53 99:1 
aReaction conditions: 2H-azirine (0.5 mmol), anhydrous THF (4 mL), isocyanide (1.1 equiv.), carboxylic acid (1.1 equiv.), anhydrous ZnCl2 (25 mol%), 
argon atmosphere, 55 °C, 4 h. b6 h reaction time was necessary. cIsolated yield of the major trans diastereomer. dNMR yield was determined by 1H NMR 
with 1,3,5-trimethoxybenzene as internal standard. etrans/cis diastereomeric ratio (determined from crude reaction mixture by LC-MS). fDiastereomeric 
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In order to evaluate the suitability of the developed 
JU-3CR for the construction of aziridine 
peptidomimetics, we reacted N-protected amino acids (L-
glutamic acid, L-glutamine, β-alanine and D-
phenylglycine derivatives) with rac-1a and 2a under the 
optimized conditions. We were pleased to find that the 
reaction proceeded well and gave peptides 4{45–48} in 
64–82% isolated yields with high diastereoselectivities 
(trans:cis dr) (Table 5). 
Table 5. Utilization of N-protected aminio acids.a 
 
aReaction conditions: 2H-azirine (0.5 mmol), anhydrous THF (4 mL), 
isocyanide (1.1 equiv.), amino acid (1.1 equiv.) anhydrous ZnCl2 (25 
mol%), argon atmosphere, 55 °C, 4 h. bCombined isolated yield of the 
two trans diastereomers (NMR yield in parenthesis). NMR yield was 
determined by 1H NMR with 1,3,5-trimethoxybenzene as internal 
standard. cDiastereomeric ratio (trans:trans:cis:cis), determined from 
the crude reaction mixture by LC-MS, dDiastereomeric ratio (trans:cis), 
eIsolated yield of trans diastereomer (NMR yield in parenthesis). 
Moreover, we investigated the reaction with optically 
active 2H-azirine carboxylic ester (-)-(R)-1a (Scheme 
2.).16d Compound (+)-(2R,3R)-4{1} was formed smoothly 
with no loss of chirality (72% ee). In addition, 
recrystallization from diethyl ether led to 92% 
enantiomeric excess (determined by chiral column 
chromatography). 
 
Scheme 2. Reaction with optically active 2H-azirine. 
Transformations of the N-acylaziridine products  
To demonstrate the utility of the JU-3CR products, 
other transformations were also performed. First, 
aziridine esters 4{1}, 4{11} and 4{12} were subjected to 
alkaline hydrolysis followed by EDC/HOBt-mediated 
amide coupling to give N-acylaziridine-2,3-
dicarboxamides 6–11 (Table 6). To our delight, the 
multisubstituted aziridine ring withstood the conditions 
of hydrolysis and coupling reaction affording the 
corresponding dicarboxamides 6–11 in 71–95% isolated 
yields. 
Table 6. Synthesis of N-acylaziridine-2,3-dicarboxamides.a
 
aReaction conditions for hydrolysis: rac-N-acylaziridine (0.5 mmol), 
THF (0.65 mL), aq. NaOH (1.16 equiv.; 1 M solution), rt, 12 h. 
Reaction conditions for coupling: DMF (5 mL), EDC hydrochloride 
(1.16 equiv.), amine (1.0 equiv.) and HOBt (1.38 equiv.), rt, 12 h. 
Furthermore, N-unsubstituted aziridine (±)-4{10} 
could also be obtained by deprotecting the N-
trifluoroacetylated derivative (Scheme 3). Treatment with 
sodium borohydride in EtOH led to compound (±)-12 in 
a yield of 92% under mild conditions. According to our 
knowledge, this is the first example for the removal of a 
trifluoroacetyl group from aziridine with NaBH4. 
 
Scheme 3. Synthesis of N-unsubstituted aziridine derivative 12. 
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Finally, ring-opening and ring-expansion reactions of 
the JU-3CR products were investigated. Since N-
acylaziridine-2-carboxamides can be regarded as 
functionalized α/β -amino acids, their ring opening 
reactions with water result in highly desirable α-hydroxy-
β-amino or β-hydroxy- α-amino acids (mostly catalysed 
by Lewis acids,19 eg. BF3·2H2O).
20 On the other hand, N-
acylaziridines can rearrange into oxazolines, promoted 
under thermal, acidic or nucleophilic (eg. NaI) 
conditions.21 It is notable that the stereo- and regio-
chemical outcomes of these reactions greatly depend on 
both the substitution pattern of the aziridine ring and 
reaction conditions. The ring expansion of (±)-4{1} and 
(±)-5{1} smoothly occured in the presence of NaI in 
DMF with retention of configuration, and afforded the 
corresponding trans-13 and cis-14 oxazolines 
stereoselectively22 (Scheme 4, Method A, 78% and 80% 
isolated yields). Unexpectedly, three equivalents of 
BF3·2H2O in DCM also enabled access to oxazolines, 
though with inversed regioselectivity (and with the 
retention of configuration)22 (Scheme 4, Method B, 85% 
and 72% isolated yields). These observations clearly 
show that the nucleophilic attack can occur 
regioselectively at both C2 and C3 depending on reaction 





















































Scheme 4. Ring expansion to oxazolines 13–16. 
The ring opening of N-acylaziridine 4{1} with water 
was successfully accomplished in the presence of 
Sc(OTf)3 catalyst (Scheme 5). The nucleophilic attack 
occured regioselectively at the C3 position, and afforded 
β-hydroxy-α-amino acid 17 in a yield of 72% (Scheme 
5).  Since the mechanism of the ring opening involves an 
electron-deficient tertiary carbon atom (C3), and requires 
Lewis acid catalysis, both inversion (SN2) and retention 
(Lewis acid-mediated SN1 mechanism)
23 of C3 
configuration could be assumed. In order to determine 
the stereochemical outcome of the ring opening reaction, 
however, needs further analytical investigation of product 
17. 
 
Scheme 5. Ring opening reaction with water. 
Conclusion 
We established a straightforward, one-pot, 
diastereoselective procedure for the preparation of N-
acylaziridine-2-carboxamide derivatives through a 
newly-developed Jullié–Ugi three-component reaction 
between 2H-azirines, isocyanides and carboxylic acids. 
This robust method tolerates both electron-rich and 
electron-deficient substrates in all combinations, 
affording the target multisubstituted aziridines in high 
diversity with good yields . This MCR procedure also 
enables the synthesis of short aziridine-based 
peptidomimetics by coupling N-protected amino acids as 
the carboxylic acid component in a one-step operation. 
Moreover, the JU-3CR products were converted to N-
unsubstituted aziridine and dicarboxamide derivatives. In 
addition, their regioselective transformation to oxazolines 
and the synthesis of a β-hydroxy-α-amino acid derivative 
were also accomplished.  
Experimental Section 
General information: All NMR spectra were recorded 
at 298 K on a Bruker Avance 500 spectrometer in CDCl3-
d1 or DMSO-d6. Chemical shifts are reported in δ (ppm) 
relative to the internal standard (TMS) or the residual 
solvent signal. Data are reported as follows: chemical 
shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet, dd = doublet of doublet, dt = 
doublet of triplet etc.), coupling constants (Hz), and 
integration. High-resolution mass spectra (HRMS) were 
measured on a Thermo Scientific Q Exactive hybrid 
quadrupole-Orbitrap mass spectrometer using HESI ion 
source. Samples (5 µL from 1 µg/ml solution) were 
injected to the MS using flow injection method (200 
µL/min, water: MeCN 1:1, 0.1% TFA). Melting points 
(mp) were recorded with an Opti Melt Automated 
Melting Point System (SRS, Stanford research system). 
Optical rotation was measured on an Optical Activity 
AA-55 polarimeter (Optical Activity Ltd.). HPLC-MS 
analyses were performed on an Agilent 1200 Series 
equipment with a Waters SQ or Agilent G1946D MS 
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detector (ESI, operated in positive mode) with Luna 
C18(2) column (100 Å, 10 µm, 250 x 4.6 mm, 
Phenomenex) or Kinetex C18 column (100 Å, 5 µm, 250 
x 4.6 mm, Phenomenex). The enantiomeric excess was 
determined by chiral HPLC analysis on a Shimadzu LC-
10 VP series equipment with Phenomenex Lux 
Cellulose-1 column (5µm, 150 x 4.6 mm). Column 
chromatographies were performed on silica gel (60 Å, 
0.063‒0.200 mm) from Merck. TLC was performed on 
fluorescent-indicating plates (aluminum sheets precoated 
with silica gel 60F254, 1.05554, Merck), and visualization 
was achieved by UV light (254 nm). Microwave-assisted 
experiments were conducted using a CEM Discover 
System in closed vessels under magnetic stirring 
(temperature was monitored by the built-in external 
surface sensor). Aromatic isocyanides (4-nitrophenyl 
isocyanide and 3,4,5-trimethoxyphenyl isocyanide) were 
prepared according to a known procedure.24 Racemic 2H-
azirines16 1a, 1b, 1e, 1f and optically active 2H-azirine16d 
(R)-1a were synthesized according to literature 
procedures. All other reagents and solvents were 
commercially available and used without further 
purification. 
Modified procedure and characterization data for 
racemic 2H-azirines 1c and 1d:  
(±)-Ethyl 2,3-dimethyl-2H-azirine-2-carboxylate (1c)
 
16a-e: To a solution of NH2OH·HCl (14.9 mmol, 1.1 
equiv.) and NaOH (14.9 mmol, 1.1 equiv.) in 20 mL 
MeOH ethyl 2-methyl-3-oxobutanoate was added 
dropwise (13.5 mmol, 1.0 equiv.) at room temperature. 
After stirring for 2 h, the solvent was removed under 
reduced pressure. Then 10 mL water was added to the 
residue, and extracted three times with EtOAc (3 x 30 
mL). The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo to give ethyl 3-
(hydroxyimino)-2-methylbutanoate, which was used for 
the next step without purification. 
The crude ketoxime was dissolved immediately in DCM 
(30 mL) then  pyridine (13.5 mmol, 1.0 equiv.) and p-
toluenesulfonyl chloride (14.9 mmol, 1.1 equiv.) in DCM 
(20 mL) were added at 0 °C. Then the reaction mixture 
was stirred for 6 h at 25 °C and after completion of the 
reaction the solvent was removed in vacuo. Then water 
(20 mL) was added, and extracted two times with CHCl3 
(2 x 25 mL). The combined organic layers were dried 
over Na2SO4 and concentrated in vacuo. The crude 
material was purified by flash chromatography to yield 
ethyl 2-methyl-3-((tosyloxy)imino)butanoate (2.8 g, 
67%). 
To a stirred solution of ketoximetosylate (2.8 g, 8.9 
mmol) in 20 mL DCM, triethylamine (9.8 mmol, 1.1 
equiv.) was added dropwise at 0 °C. After stirring at 0 °C 
for 30 min, the mixture was warmed to room temperature 
and the stirring was continued for 6 h. After the reaction 
was completed, dilute aqueous HCl (60 mL, 0.05 M) was 
added and extracted twice with DCM (50 mL). The 
combined organic layers were dried over Na2SO4 and 
concentrated in vacuo. Finally the crude product was 
purified by vacuum distillation to afford the desired 2H-
azirine product (904 mg, 72%) as colorless oil. Silica gel 
TLC Rf = 0.64 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 4.05 (qq, J = 6.9, 3.8 Hz, 2H), 2.47 (s, 
3H), 1.33 (s, 3H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (126 
MHz, DMSO) δ 173.3, 164.3, 61.1, 33.5, 17.8, 14.6, 
11.8. HRMS (ESI) m/z: [M+H]+ Calcd for C7H12NO2  
142.0868; Found 142.0863. 
(±)-Ethyl 2-benzyl-3-methyl-2H-azirine-2-carboxylate 
(1d): Ethyl 2-benzyl-3-oxo-butyrate was prepared 
according to the literature.25 
Ethyl 2-benzyl-3-oxo-butyrate (7.7 mmol, 1.0 equiv) was 
gradually added to a solution of NH2OH·HCl (7.7 mmol, 
1.0 equiv) in pyridine (7 mL) at 0 °C. The solution was 
stirred for 4 h at 25 °C. Then p-toluenesulfonyl chloride 
(16.9 mmol, 2.2 equiv) was added to the reaction mixture 
at 0 °C followed by stirring for 12 h at room temperature. 
After the reaction was completed, aqueous HCl (40 mL, 
1 M) was added, and extracted with DCM (2 x 30 mL). 
The combined organic layers were dried over Na2SO4 
and the solvent was evaporated under reduced pressure. 
The crude material was purified by column 
chromatography using hexane/ethyl acetate: 10/1 to 
afford ethyl 2-benzyl-3-((tosyloxy)imino)butanoate (1.27 
g, 84%) as colorless oil. Silica gel TLC Rf = 0.58 
(hexane/EtOAc = 2/1). 1H NMR (500 MHz, DMSO-d6) 
two isomers (60:40): δ 7.67 (t, J = 8.7 Hz, 4H), 7.43 (t, J 
= 9.2 Hz, 4H), 7.26 – 7.16 (m, 4H), 7.16 – 7.12 (m, 2H), 
7.10 (d, J = 6.8 Hz, 2H), 7.05 (d, J = 6.4 Hz, 2H), 4.21 (t, 
J = 8.2 Hz, 1H), 4.10 – 3.93 (m, 4H), 3.71 (t, J = 8.1 Hz, 
1H), 3.16 (dd, J = 13.9, 6.6 Hz, 1H), 3.04 (dd, J = 14.2, 
7.3 Hz, 1H), 2.94 – 2.83 (m, 2H), 2.40 (s, 6H), 1.90 (s, 
3H), 1.72 (s, 3H), 1.09 (t, J = 7.1 Hz, 3H), 1.02 (t, J = 7.1 
Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 169.3, 168.7, 
165.1, 163.9, 145.3, 145.2, 137.4, 137.2, 131.9, 131.9, 
130.0, 129.9, 128.7, 128.6, 128.4, 128.2, 128.2, 126.7, 
126.4, 61.2, 61.1, 52.0, 47.3, 33.7, 33.3, 21.2, 18.4, 14.3, 
13.8, 13.8. HRMS (ESI) m/z: [M+H]+ Calcd for 
C20H24NO5S  390.1375; Found 390.1372. 
To a solution of ethyl 2-benzyl-3-
((tosyloxy)imino)butanoate (3.3 mmol) in anhydrous 
THF (8 mL) was added dropwise a solution of DBU (5 
mmol, 1.5 equiv.) in anhydrous THF (3.5 mL) at 0 °C. 
The reaction mixture was allowed to warm up to room 
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temperature and then stirred until full conversion 
monitored by TLC (1 h). Then, the solvent was removed 
under reduced pressure and the residue was purified by 
column chromatography (hexane/EtOAc : 6/1, silica gel) 
to give ethyl 2-benzyl-3-methyl-2H-azirine-2-carboxylate 
(558 mg, 78%) as colorless oil. Silica gel TLC Rf = 0.70 
(hexane/EtOAc = 2/1). 1H NMR (500 MHz, DMSO-d6) δ 
7.25 (t, J = 7.4 Hz, 2H), 7.17 (t, J = 7.4 Hz, 1H), 7.13 (d, 
J = 6.8 Hz, 2H), 4.02 (qq, J = 7.0, 3.7 Hz, 2H), 3.25 (d, J 
= 14.9 Hz, 1H), 3.01 (d, J = 14.9 Hz, 1H), 2.30 (s, 3H), 
1.11 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) 
δ 172.7, 163.5, 137.9, 129.9, 128.7, 126.7, 61.3, 38.1, 
36.8, 14.5, 12.3. HRMS (ESI) m/z: [M+H]+ Calcd for 
C13H16NO2 218.1181; Found 218.1176. 
General procedure and characterization data for N-
acylaziridine products 4 and 5: To a solution of 2H-
azirine (0.5 mmol) in anhydrous THF (4 mL), the 
corresponding isocyanide (1.1 equiv), carboxylic acid 
(1.1 equiv) and anhydrous ZnCl2 (25 mol%) were added 
under argon atmosphere. The reaction mixture was stirred 
for 4–6 h at 55 °C until the 2H-azirine was completely 
consumed (monitored by TLC). Then the solvent was 
removed under reduced pressure and the residue was 
purified by silica gel column chromatography (eluent: 
hexane/EtOAc). 
(±)-Ethyl trans-1-benzoyl-3-(tert-butylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-4{1}): White solid, 
115 mg, 69% yield, mp 102–103 °C. Silica gel TLC Rf = 
0.46 (hexane/EtOAc = 2/1). 1H NMR (500 MHz, DMSO-
d6) δ 7.73 (d, J = 7.4 Hz, 2H), 7.56 (t, J = 7.3 Hz, 1H), 
7.46 (t, J = 7.6 Hz, 2H), 7.20 (s, 1H), 4.26 – 4.12 (m, 
2H), 3.53 (s, 1H), 1.71 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H), 
0.96 (s, 9H); 13C NMR (126 MHz, DMSO-d6) δ 174.8, 
166.7, 164.5, 133.3, 132.5, 128.5, 128.0, 61.5, 51.5, 49.8, 
42.9, 27.7, 14.1, 13.7. HRMS (ESI) m/z: [M+H]+ Calcd 
for C18H25N2O4  333.1814; Found 333.1817. 
(2R,3R)-Ethyl 1-benzoyl-3-(tert-butylcarbamoyl)-3-
methylaziridine-2-carboxylate ((2R,3R)-4{1}): After 
column chromatography: white solid, 113 mg, 68% yield, 
72% ee. The resulting solid was recrystallized from 
diethyl ether (2 mL) at 0 °C. White solid, 35% yield, 92% 
ee, [α]23 + 27.1° (c 0.7, CHCl3). 
(±)-Ethyl cis-1-benzoyl-3-(tert-butylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-5{1}): White solid, 
7 mg, 4% yield, mp 58–88 °C. Silica gel TLC Rf = 0.67 
(hexane/EtOAc = 2/1). 1H NMR (500 MHz, DMSO-d6) δ 
8.13 (d, J = 7.6 Hz, 2H), 7.67 (t, J = 7.3 Hz, 1H), 7.55 (t, 
J = 7.5 Hz, 2H), 7.27 (s, 1H), 4.24 – 4.06 (m, 2H), 3.52 
(s, 1H), 1.29 (s, 3H), 1.25 (s, 9H), 1.24 – 1.21 (m, 3H, 
overlap with isocyanide). 13C NMR (126 MHz, DMSO-
d6) δ 174.5, 166.2, 165.0, 133.6, 132.5, 128.9, 128.8, 
61.5, 50.9, 50.6, 45.1, 28.2, 17.7, 14.0. HRMS (ESI) m/z: 




(rac-4{2}): White solid, 144 mg 79% yield, mp 100–102 
°C. Silica gel TLC Rf = 0.38 (hexane/EtOAc = 2/1). 
1H 
NMR (500 MHz, DMSO-d6) δ 7.37 (t, J = 7.8 Hz, 1H), 
7.31 (d, J = 7.5 Hz, 1H), 7.23 (s, 1H), 7.21 (s, 1H), 7.12 
(d, J = 7.9 Hz, 1H), 4.27 – 4.12 (m, 2H), 3.78 (s, 3H), 
3.52 (s, 1H), 1.69 (s, 3H), 1.23 (t, J = 7.1 Hz, 3H), 0.99 
(s, 9H). 13C NMR (126 MHz, DMSO-d6) δ 174.5, 166.6, 
164.5, 159.2, 134.7, 129.7, 120.4, 118.8, 112.4, 61.5, 
55.3, 51.5, 49.7, 43.0, 27.8, 14.1, 13.8. HRMS (ESI) m/z: 




(rac-4{3}): White solid, 98 mg, 56% yield, mp 185–187 
°C. Silica gel TLC Rf = 0.12 (hexane/EtOAc = 2/1).
 1H 
NMR (500 MHz, DMSO-d6) δ 10.17 (s, 1H), 7.59 (d, J = 
8.4 Hz, 2H), 7.12 (s, 1H), 6.79 (d, J = 8.5 Hz, 2H), 4.25 – 
4.12 (m, 2H), 3.54 (s, 1H), 1.67 (s, 3H), 1.22 (t, J = 7.1 
Hz, 3H), 0.98 (s, 9H). 13C NMR (126 MHz, DMSO-d6) δ 
174.0, 166.9, 164.5, 161.5, 130.4, 124.1, 115.1, 61.3, 
51.4, 49.7, 42.7, 27.8, 14.1, 13.7. HRMS (ESI) m/z: 




4{4}): White solid, 103 mg, 61% yield, mp 102–103 °C. 
Silica gel TLC Rf = 0.50 (hexane/EtOAc = 2/1).
 1H NMR 
(500 MHz, DMSO-d6) δ 7.69 (d, J = 7.6 Hz, 1H), 7.50 – 
7.45 (m, 2H), 7.44 – 7.37 (m, 1H), 7.13 (s, 1H), 4.24 – 
4.11 (m, 2H), 3.48 (s, 1H), 1.60 (s, 3H), 1.21 (t, J = 7.1 
Hz, 3H), 1.02 (s, 9H). 13C NMR (126 MHz, DMSO-d6) δ 
173.3, 166.3, 164.7, 132.8, 132.5, 132.0, 131.0, 130.7, 
127.0, 61.5, 51.5, 49.3, 43.5, 27.9, 14.1, 13.3. HRMS 




White solid, 119 mg, 69% yield, mp 107–108 °C. Silica 
gel TLC Rf = 0.44 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.33 – 7.28 (m, 2H), 7.28 (s, 1H), 
7.25 – 7.18 (m, 3H), 4.24 – 4.05 (m, 2H), 3.56 (q, J = 
16.0 Hz, 2H), 3.23 (s, 1H), 1.38 (s, 3H), 1.29 (s, 9H), 
1.19 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) 
δ 179.2, 166.4, 165.8, 134.6, 129.9, 128.2, 126.7, 61.3, 
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51.7, 49.0, 43.5, 42.66, 28.2, 14.1, 13.4. HRMS (ESI) 




carboxylate (rac-4{6}): White solid, 135 mg, 60%, mp 
131–132 °C. Silica gel TLC Rf = 0.41 (hexane/EtOAc = 
1/1). 1H NMR (500 MHz, DMSO-d6) δ 7.37 (d, J = 15.9 
Hz, 1H), 7.31 (s, 1H), 7.01 (s, 2H), 6.60 (d, J = 15.9 Hz, 
1H), 4.26 – 4.13 (m, 2H), 3.80 (s, 6H), 3.68 (s, 3H), 3.52 
(s, 1H), 1.64 (s, 3H), 1.26 – 1.20 (m, 3H), 1.18 (s, 9H). 
13C NMR (126 MHz, DMSO-d6) δ 173.4, 166.7, 164.8, 
153.1, 142.2, 139.5, 129.9, 120.6, 106.1, 61.3, 60.2, 56.2, 
51.6, 49.0, 42.8, 28.1, 14.1, 13.9. HRMS (ESI) m/z: 
[M+H]+ Calcd for C23H33N2O7  449.2288; Found 
449.2294. 
(±)-Ethyl trans-3-(tert-butylcarbamoyl)-3-methyl-1-
nicotinoylaziridine-2-carboxylate (rac-4{7}): White 
solid, 47 mg, 28%,  mp 114–116 °C. Silica gel TLC Rf = 
0.29 (hexane/EtOAc = 1/2). 1H NMR (500 MHz, DMSO-
d6) δ 8.87 (s, 1H), 8.73 (d, J = 3.7 Hz, 1H), 8.07 (d, J = 
7.9 Hz, 1H), 7.51 (dd, J = 7.6, 4.9 Hz, 1H), 7.32 (s, 1H), 
4.27 – 4.13 (m, 2H), 3.54 (s, 1H), 1.72 (s, 3H), 1.29 – 
1.17 (m, 3H), 0.97 (s, 9H). 13C NMR (126 MHz, DMSO-
d6) δ 173.8, 166.4, 164.5, 153.0, 148.6, 135.6, 129.2, 
123.8, 61.6, 51.6, 50.0, 43.11, 27.7, 14.1, 13.7. HRMS 
(ESI) m/z: [M+H]+ Calcd for C17H24N3O4  334.1767; 
Found 334.1767. 
(±)-Ethyl trans-1-acetyl-3-(tert-butylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-4{8}): White solid, 
102 mg, 75%, mp 101–102 °C. Silica gel TLC Rf = 0.31 
(hexane/EtOAc = 2/1). 1H NMR (500 MHz, DMSO-d6) δ 
7.31 (s, 1H), 4.25 – 4.07 (m, 2H), 3.28 (s, 1H), 1.91 (s, 
3H), 1.53 (s, 3H), 1.27 (s, 9H), 1.21 (t, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, DMSO-d6) δ 178.0, 166.5, 165.5, 
61.3, 51.7, 48.3, 42.9, 28.2, 23.9, 14.1, 13.5. HRMS 




4{9}): White solid, 84 mg, 55%, mp 93–94 °C. Silica gel 
TLC Rf = 0.51 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.43 (s, 1H), 4.28 – 4.10 (m, 4H), 
3.20 (s, 1H), 1.60 (s, 3H), 1.26 (s, 9H), 1.22 (t, J = 7.1 
Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 175.7, 166.1, 
165.8, 61.5, 51.7, 50.5, 44.0, 42.6, 28.1, 14.1, 13.7. 
HRMS (ESI) m/z: [M+H]+ Calcd for C13H22ClN2O4  
305.1268; Found 305.1269. 
(±)-Ethyl trans-3-(tert-butylcarbamoyl)-3-methyl-1-
(2,2,2-trifluoroacetyl)aziridine-2-carboxylate (rac-
4{10}): White solid, 87 mg, 54%, mp 94–95 °C. Silica 
gel TLC Rf = 0.53 (hexane/EtOAc = 2/1).
 1H NMR (500 
MHz, DMSO-d6) δ 7.87 (s, 1H), 4.31 – 4.12 (m, 2H), 
3.30 (s, 1H), 1.64 (s, 3H), 1.25 (s, 9H), 1.24 – 1.20 (m, 
3H). 13C NMR (126 MHz, DMSO-d6) δ 166.08 (q, J = 
36.6 Hz), 165.5, 164.9, 115.33 (q, J = 287.5 Hz), 62.0, 
54.0, 52.1, 41.6, 27.9, 14.0, 13.4. HRMS (ESI) m/z: 




carboxylate  (rac-4{11}): White solid, 151 mg, 78%, mp 
83–84 °C. Silica gel TLC Rf = 0.61 (hexane/EtOAc = 
2/1). 1H NMR (500 MHz, DMSO-d6) δ 7.73 (d, J = 7.7 
Hz, 2H), 7.55 (t, J = 7.2 Hz, 1H), 7.45 (t, J = 7.5 Hz, 2H), 
7.03 (s, 1H), 4.29 – 4.09 (m, 2H), 3.42 (s, 1H), 1.71 (s, 
3H), 1.55 (d, J = 14.7 Hz, 1H), 1.35 (d, J = 14.7 Hz, 1H), 
1.22 (t, J = 7.0 Hz, 3H), 1.06 (s, 3H), 0.99 (s, 3H), 0.80 
(s, 9H). 13C NMR (126 MHz, DMSO-d6) δ 174.9, 166.6, 
164.4, 133.7, 132.4, 128.5, 127.9, 61.4, 55.3, 50.0, 49.8, 
42.8, 31.2, 31.1, 28.4, 28.2, 14.1, 13.7. HRMS (ESI) m/z: 
[M+H]+ Calcd for C22H33N2O4  389.2440; Found 
389.2439. 
(±)-Ethyl trans-1-benzoyl-3-(cyclohexylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-4{12}): White 
solid, 127 mg, 71%, mp 166–167 °C. Silica gel TLC Rf = 
0.67 (hexane/EtOAc = 1/1). 1H NMR (500 MHz, DMSO-
d6) δ 7.87 (d, J = 7.9 Hz, 1H), 7.71 (d, J = 7.2 Hz, 2H), 
7.56 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.6 Hz, 2H), 4.26 – 
4.12 (m, 2H), 3.54 (s, 1H), 3.25 (ddd, J = 14.9, 11.5, 5.9 
Hz, 1H), 1.69 (s, 3H), 1.58 (dd, J = 22.6, 12.7 Hz, 2H), 
1.46 (d, J = 9.3 Hz, 2H), 1.23 (t, J = 7.1 Hz, 3H), 1.20 – 
0.82 (m, 6H). 13C NMR (126 MHz, DMSO-d6) δ 174.7, 
166.6, 164.3, 133.3, 132.5, 128.6, 127.9, 61.5, 49.3, 49.0, 
43.1, 31.5, 31.4, 25.1, 24.8, 24.7, 14.1, 13.6. HRMS 
(ESI) m/z: [M+H]+ Calcd for C20H27N2O4  359.1971; 
Found 359.1972. 
(±)-Ethyl trans-1-benzoyl-3-(benzylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-4{13}): White 
solid, 106 mg, 58%, mp 121–123 °C. Silica gel TLC Rf = 
0.59 (hexane/EtOAc = 1/1). 1H NMR (500 MHz, DMSO-
d6) δ 8.82 (t, J = 5.4 Hz, 1H), 7.76 (d, J = 7.8 Hz, 2H), 
7.63 (t, J = 7.3 Hz, 1H), 7.49 (t, J = 7.4 Hz, 2H), 7.19 – 
7.10 (m, 3H), 6.80 (d, J = 3.8 Hz, 2H), 4.28 (dd, J = 15.2, 
6.6 Hz, 1H), 4.25 – 4.16 (m, 2H), 3.96 (dd, J = 15.2, 5.0 
Hz, 1H), 3.56 (s, 1H), 1.74 (s, 3H), 1.23 (t, J = 7.0 Hz, 
3H). 13C NMR (126 MHz, DMSO-d6) δ 174.7, 166.4, 
165.8, 138.5, 133.4, 132.7, 128.70, 128.2, 128.0, 126.7, 
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126.7, 61.5, 49.0, 43.3, 42.9, 14.1, 13.7. HRMS (ESI) 




(rac-4{14}): White solid, 84 mg, 38%, mp 140–141 °C. 
Silica gel TLC Rf = 0.36 (hexane/EtOAc = 1/1). 
1H NMR 
(500 MHz, DMSO-d6) δ 9.70 (s, 1H), 7.82 (d, J = 7.4 Hz, 
2H), 7.58 (t, J = 7.1 Hz, 1H), 7.49 (t, J = 7.3 Hz, 2H), 
6.66 (s, 2H), 4.21 (dd, J = 13.5, 6.5 Hz, 2H), 3.68 (s, 1H), 
3.63 (s, 6H), 3.57 (s, 3H), 1.83 (s, 3H), 1.23 (t, J = 6.9 
Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 174.3, 166.2, 
164.6, 152.5, 134.5, 133.5, 133.3, 132.8, 128.7, 128.0, 
99.5, 61.6, 60.1, 55.8, 49.4, 43.6, 14.1, 13.6. HRMS 




4{15}): Pale yellow solid, 120 mg, 60%, mp 141–143 °C. 
Silica gel TLC Rf = 0.66 (hexane/EtOAc = 1/1). 
1H NMR 
(500 MHz, DMSO-d6) δ 10.31 (s, 1H), 8.16 (d, J = 9.1 
Hz, 2H), 7.84 (d, J = 7.4 Hz, 2H), 7.73 (d, J = 9.1 Hz, 
2H), 7.57 (t, J = 7.3 Hz, 1H), 7.48 (t, J = 7.6 Hz, 2H), 
4.28 – 4.12 (m, 2H), 3.75 (s, 1H), 1.87 (s, 3H), 1.22 (t, J 
= 7.1 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 174.0, 
166.0, 165.9, 143.9, 143.2, 133.2, 132.8, 128.8, 128.0, 
124.5, 120.8, 61.7, 49.5, 43.75, 14.0, 13.4. HRMS (ESI) 




carboxylate (rac-4{16}): White solid, 149 mg, 77%, mp 
95–96 °C. Silica gel TLC Rf= 0.59 (hexane/EtOAc = 
2/1). 1H NMR (500 MHz, DMSO-d6) δ 7.32 – 7.25 (m, 
2H), 7.24 – 7.19 (m, 3H), 7.14 (s, 1H), 4.21 – 4.02 (m, 
2H), 3.57 (q, J = 16.0 Hz, 2H), 3.14 (s, 1H), 1.84 (d, J = 
14.7 Hz, 1H), 1.56 (d, J = 14.7 Hz, 1H), 1.39 (s, 3H), 
1.34 (s, 6H), 1.18 (t, J = 7.0 Hz, 3H), 0.94 (s, 9H). 13C 
NMR (126 MHz, DMSO-d6) δ 179.2, 166.3, 165.6, 
134.7, 129.9, 128.2, 126.6, 61.3, 55.5, 50.0, 49.3, 43.7, 
42.5, 31.4, 31.2, 29.1, 28.6, 14.1, 13.4. HRMS (ESI) m/z: 




White solid, 142 mg, 79%, mp 90–91 °C. Silica gel TLC 
Rf= 0.30 (hexane/EtOAc = 2/1).
 1H NMR (500 MHz, 
DMSO-d6) δ 8.27 (t, J = 4.5 Hz, 1H), 7.28 (t, J = 7.3 Hz, 
2H), 7.24 – 7.17 (m, 3H), 4.23 – 3.98 (m, 2H), 3.63 – 
3.43 (m, 2H), 3.29 (s, 1H), 3.22 – 2.97 (m, 2H), 1.51 – 
1.40 (m, 2H), 1.34 (s, 3H), 1.32 – 1.22 (m, 4H), 1.19 (t, J 
= 7.1 Hz, 3H), 0.84 (t, J = 6.9 Hz, 3H). 13C NMR (126 
MHz, DMSO-d6) δ 179.1, 166.3, 166.1, 134.5, 129.9, 
128.2, 126.7, 61.3, 48.1, 43.4, 43.0, 28.6, 28.5, 21.8, 
14.05, 13.9, 13.3. HRMS (ESI) m/z: [M+H]+ Calcd for 
C20H29N2O4  361.2127; Found 361.2130. 
(±)-Ethyl trans-1-acetyl-3-(cyclohexylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-4{18}): White 
solid, 101 mg, 68%, mp 97–98 °C. Silica gel TLC Rf = 
0.55 (hexane/EtOAc = 1/1). 1H NMR (500 MHz, DMSO-
d6) δ 7.97 (d, J = 7.5 Hz, 1H), 4.24 – 4.06 (m, 2H), 3.54 
(d, J = 7.5 Hz, 1H), 3.31 (s, 1H), 1.89 (s, 3H), 1.72 (d, J 
= 40.2 Hz, 4H), 1.56 (d, J = 12.4 Hz, 1H), 1.50 (s, 3H), 
1.32 – 1.17 (m,4H), 1.20 (t, J = 6.6 Hz, 3H), 1.15 – 0.97 
(m, 1H). 13C NMR (126 MHz, DMSO-d6) δ 178.0, 166.4, 
165.1, 61.3, 49.3, 47.7, 43.1, 32.1, 31.8, 25.1, 24.9, 24.9, 
23.8, 14.1, 13.4. HRMS (ESI) m/z: [M+H]+ Calcd for 
C15H25N2O4  297.1814; Found 297.1815. 
(±)-Ethyl trans-3-(cyclohexylcarbamoyl)-3-methyl-1-
(2-phenylacetyl)aziridine-2-carboxylate (rac-4{19}): 
White solid, 112 mg, 60%, mp 101–102 °C. Silica gel 
TLC Rf = 0.35 (hexane/EtOAc = 2/1), 
1H NMR (500 
MHz, DMSO-d6) δ 7.92 (d, J = 7.6 Hz, 1H), 7.28 (t, J = 
7.2 Hz, 2H), 7.25 – 7.15 (m, 3H), 4.22 – 3.96 (m, 2H), 
3.62 – 3.56 (m, 1H), 3.54 (s, 2H), 3.28 (s, 1H), 1.79 – 
1.63 (m, 4H), 1.60 – 1.51 (m, 1H), 1.32 (s, 3H), 1.29 – 
1.21 (m, 4H), 1.19 (t, J = 7.1 Hz, 3H), 1.14 – 1.00 (m, 
1H). 13C NMR (126 MHz, DMSO-d6) δ 179.2, 166.3, 
165.3, 134.6, 129.9, 128.2, 126.7, 61.3, 49.4, 48.3, 43.5, 
43.0, 32.1, 31.9, 25.2, 24.9, 14.1, 13.3. HRMS (ESI) m/z: 




4{20}): White solid, 160 mg, 80% yield, mp 143–144 °C. 
Silica gel TLC Rf = 0.61 (hexane/EtOAc = 2/1). 
1H NMR 
(500 MHz, DMSO-d6) δ 7.81 (d, J = 7.6 Hz, 1H), 6.82 (s, 
2H), 4.12 (q, J = 7.1 Hz, 2H), 3.57 (s, 1H), 3.50 – 3.40 
(m, 1H), 2.28 (s, 6H), 2.19 (s, 3H), 1.61 (dd, J = 32.6, 
16.0 Hz, 3H), 1.57 – 1.41 (m, 5H), 1.29 (s, 2H), 1.20 – 
1.13 (m, 4H), 1.15 – 0.98 (m, 2H). 13C NMR (126 MHz, 
DMSO-d6) δ 175.8, 166.3, 164.1, 138.8, 135.8, 132.2, 
128.6, 61.4, 49.2, 48.3, 42.6, 31.8, 25.2, 24.9, 24.8, 20.6, 
20.0, 14.0, 13.4. HRMS (ESI) m/z: [M+H]+ Calcd for 
C23H33N2O4  401.2440; Found 401.2442. 
(±)-Ethyl trans-3-(cyclohexylcarbamoyl)-1-(3-
fluorobenzoyl)-3-methylaziridine-2-carboxylate (rac-
4{21}): White solid, 145 mg, 77% yield, mp 165–167 °C. 
Silica gel TLC Rf = 0.39 (hexane/EtOAc = 2/1). 
1H NMR 
(500 MHz, DMSO-d6) δ 7.94 (d, J = 7.9 Hz, 1H), 7.58 – 
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7.49 (m, 2H), 7.45 – 7.39 (m, 2H), 4.27 – 4.14 (m, 2H), 
3.54 (s, 1H), 3.29 – 3.20 (m, 1H), 1.69 (s, 3H), 1.65 – 
1.53 (m, 2H), 1.48 (s, 2H), 1.22 (t, J = 7.1 Hz, 3H), 1.19 
– 0.82 (m, 6H). 13C NMR (126 MHz, DMSO-d6) δ 173.7, 
166.4, 164.3, 161.9 (d, J = 245.0 Hz), 135.7 (d, J = 6.8 
Hz), 130.9 (d, J = 7.7 Hz), 124.0, 119.5 (d, J = 21.1 Hz), 
114.3 (d, J = 22.7 Hz), 61.6, 49.4, 49.1, 43.2, 31.5, 25.0, 
24.8, 24.7, 14.1, 13.6. HRMS (ESI) m/z: [M+H]+ Calcd 
for C20H26FN2O4  377.1877; Found 377.1876. 
(±)-Ethyl trans-3-(benzylcarbamoyl)-3-methyl-1-(2-
phenylacetyl)aziridine-2-carboxylate (rac-4{22}): 
White solid, 127 mg, 67% yield, mp 123–125 °C. Silica 
gel TLC Rf = 0.25 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, CDCl3-d1) δ 7.51 – 6.85 (m, 10H), 6.35 – 6.26 (m, 
1H), 4.64 – 4.28 (m, 2H), 4.27 – 4.08 (m, 2H), 3.70 (dd, J 
= 39.2, 16.5 Hz, 2H), 3.37 (s, 1H), 1.45 (s, 3H), 1.28 (t, J 
= 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3-d1) δ 177.9, 
166.8, 165.6, 136.8, 133.5, 129.5, 128.5, 128.1, 127.5, 
127.5, 126.6, 61.6, 47.0, 43.9, 43.8, 43.5, 13.7, 11.6. 
HRMS (ESI) m/z: [M+H]+ Calcd for C22H25N2O4  
381.1814; Found 381.1814. 
(±)-Ethyl trans-3-(benzylcarbamoyl)-1-(3-
methoxybenzoyl)-3-methylaziridine-2-carboxylate 
(rac-4{23}): White solid, 104 mg, 58% yield, mp 78–79 
°C. Silica gel TLC Rf = 0.59 (hexane/EtOAc = 1/1). 
1H 
NMR (500 MHz, DMSO-d6) δ 8.84 (s, 1H), 7.45 – 7.29 
(m, 2H), 7.27 – 7.17 (m, 2H), 7.17 – 7.08 (m, 3H), 6.80 
(s, 2H), 4.30 (d, J = 12.8 Hz, 1H), 4.25 – 4.15 (m, 2H), 
3.96 (d, J = 13.6 Hz, 1H), 3.76 (s, 3H), 3.55 (s, 1H), 1.72 
(s, 3H), 1.23 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, 
DMSO-d6) δ 174.4, 166.4, 165. 7, 159.2, 138.5, 134. 7, 
129.9, 128.1, 126.7, 126.7, 120.3, 118.9, 112. 5, 61.6, 
55.3, 49.0, 43.3, 42.9, 14.1, 13.8. HRMS (ESI) m/z: 




(rac-4{24}): White solid, 27 mg, 22% yield, mp 140–142 
°C. Silica gel TLC Rf = 0.41 (hexane/EtOAc = 1/2). 
1H 
NMR (500 MHz, CDCl3-d1) δ 7.96 (s, 1H), 6.81 (s, 2H), 
4.27 (q, J = 7.4 Hz, 2H), 3.83 (s, 6H), 3.80 (s, 3H), 3.45 
(s, 1H), 2.18 (s, 3H), 1.75 (s, 3H), 1.31 (t, J = 6.7 Hz, 
3H). 13C NMR (126 MHz, CDCl3-d1) δ 176.4, 165.4, 
165.2, 152.9, 134.8, 132.4, 97.3, 62.0, 60.5, 55.7, 47.3, 
43.6, 24.0, 13.7, 10.7. HRMS (ESI) m/z: [M+H]+ Calcd 
for C18H25N2O7 381.1662; Found 381.1662. 
(±)-Ethyl trans-3-methyl-1-(2-phenylacetyl)-3-((3,4,5-
trimethoxyphenyl)carbamoyl) aziridine-2-carboxylate 
(rac-4{25}): Colorless oil, 81 mg, 36% yield. Silica gel 
TLC Rf = 0.40 (hexane/EtOAc = 1/1). 
1H NMR (500 
MHz, CDCl3-d1) δ 7.76 (s, 1H), 7.36 – 7.20 (m, 5H), 6.73 
(s, 2H), 4.23 (dd, J = 13.5, 6.6 Hz, 2H), 3.81 (s, 6H), 3.79 
(s, 3H), 3.78 – 3.68 (m, 2H), 3.37 (s, 1H), 1.60 (s, 3H), 
1.29 (t, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3-d1) 
δ 177.5, 165.3, 165.1, 152.9, 134.8, 133.4, 132.5, 129.4, 
128.2, 126.8, 97.3, 60.5, 55.7, 47.4, 43.6, 29.2, 13.7, 
11.1. HRMS (ESI) m/z: [M+H]+ Calcd for C24H29N2O7  
457.1975; Found 457.1977. 
(±)-Ethyl trans-3-methyl-1-(4-
(trifluoromethyl)benzoyl)-3-((3,4,5-trimethoxyphenyl) 
carbamoyl)aziridine-2-carboxylate (rac-4{26}): White 
solid, 74 mg, 29% yield, mp 149–150 °C. Silica gel TLC 
Rf = 0.44 (hexane/EtOAc = 1/1). 
1H NMR (500 MHz, 
DMSO-d6) δ 9.75 (s, 1H), 8.01 (d, J = 7.6 Hz, 2H), 7.87 
(d, J = 7.6 Hz, 2H), 6.66 (s, 2H), 4.22 (d, J = 6.7 Hz, 2H), 
3.70 (s, 1H), 3.63 (s, 6H), 3.57 (s, 3H), 1.85 (s, 3H), 1.22 
(t, J = 6.7 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 
173.5, 166.0, 164.6, 152.5, 137.1, 134.6, 133.4, 132.2 (q, 
J = 31.8 Hz) 128.8, 125.8, 99.35, 61.8, 60.1, 55.7, 49.9, 
43.7, 14.0, 13.5. HRMS (ESI) m/z: [M+H]+ Calcd for 
C24H26F3N2O7  511.1692; Found 511.1688. 
(±)-Ethyl trans-1-(2-chloroacetyl)-2,3-dimethyl-3-((4-
nitrophenyl)carbamoyl)aziridine-2-carboxylate (rac-
4{27}): Light-yellow solid, 104 mg, 56% yield, mp 148–
151 °C. Silica gel TLC Rf = 0.28 (hexane/EtOAc = 2/1). 
1H NMR (500 MHz, DMSO-d6) δ 10.41 (s, 1H), 8.24 (d, 
J = 9.1 Hz, 2H), 7.89 (d, J = 9.2 Hz, 2H), 4.41 (q, J = 
15.3 Hz, 2H), 4.27 – 4.17 (m, 2H), 3.52 (s, 1H), 1.78 (s, 
3H), 1.24 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, 
DMSO-d6) δ 175.1, 166.5, 165.6, 144.0, 143.3, 124.7, 
120.9, 61.8, 50.1, 44.1, 43.0, 14.1, 13.4. HRMS (ESI) 




4{28}): Light-yellow solid, 59 mg, 28% yield, mp 145–
146 °C. Silica gel TLC Rf = 0.29 (hexane/EtOAc = 2/1). 
1H NMR (500 MHz, DMSO-d6) δ 10.34 (s, 1H), 8.17 (d, 
J = 8.3 Hz, 2H), 7.75 (d, J = 8.3 Hz, 2H), 7.68 (d, J = 7.0 
Hz, 1H), 7.62 – 7.52 (m, 2H), 7.44 (t, J = 7.1 Hz, 1H), 
4.28 – 4.12 (m, 2H), 3.79 (s, 1H), 1.86 (s, 3H), 1.21 (t, J 
= 6.3 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 172.83, 
165.82 (d, J = 10.4 Hz), 162.93, 160.98, 143.89, 143.20, 
135.65 (d, J = 6.9 Hz), 131.09 (d, J = 7.6 Hz), 124.58, 
124.10, 120.73, 119.80 (d, J = 21.1 Hz), 114.48 (d, J = 
22.9 Hz), 61.82, 49.66, 43.74, 14.01, 13.26. HRMS (ESI) 
m/z: [M+H]+ Calcd for C20H19FN3O6  416.1258; Found 
416.1257. 
(±)-tert-Butyl trans-1-benzoyl-3-(tert-butylcarbamoyl)-
3-methylaziridine-2-carboxylate (rac-4{29}): White 
Page 11 of 19
ACS Paragon Plus Environment





























































solid, 110 mg, 61% yield, mp 167–168 °C. Silica gel 
TLC Rf = 0.75 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.73 (d, J = 7.4 Hz, 2H), 7.55 (t, J = 
7.1 Hz, 1H), 7.46 (t, J = 7.3 Hz, 2H), 7.13 (s, 1H), 3.44 
(s, 1H), 1.70 (s, 3H), 1.43 (s, 9H), 0.96 (s, 9H). 13C NMR 
(126 MHz, DMSO-d6) δ 174.7, 165.7, 164.7, 133.4, 
132.5, 128.5, 128.0, 82.4, 51.4, 49.2, 43.7, 27.8, 27.7, 
13.3. HRMS (ESI) m/z: [M+H]+ Calcd for C20H29N2O4  
361.2127; Found 361.2127. 
(±)-tert-Butyl trans-1-acetyl-3-(cyclohexylcarbamoyl)-
3-methylaziridine-2-carboxylate (rac-4{30}): White 
solid, 87 mg, 54% yield, mp 108–109 °C. Silica gel TLC 
Rf = 0.44 (hexane/EtOAc = 2/1). 
1H NMR (500 MHz, 
DMSO-d6) δ 7.93 (d, J = 7.6 Hz, 1H), 3.59 – 3.44 (m, 
1H), 3.22 (s, 1H), 1.87 (s, 3H), 1.75 – 1.64 (m, 4H), 1.61 
– 1.53 (m, 1H), 1.50 (s, 3H), 1.42 (s, 9H), 1.35 – 1.13 (m, 
4H), 1.13 – 0.94 (m, 1H). 13C NMR (126 MHz, DMSO-
d6) δ 178,0, 165.6, 165.3, 82.2, 49.3, 47.4, 43.8, 32.1, 
31.8, 27.7, 25.1, 24.9, 24.9, 23.8, 13.1. HRMS (ESI) m/z: 
[M+H]+ Calcd for C17H29N2O4  325.2127; Found 
325.2129. 
(±)-tert-Butyl trans-1-benzoyl-3-(benzylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-4{31}): White 
solid, 42 mg, 22% yield, mp 153–154 °C. Silica gel TLC 
Rf = 0.54 (hexane/EtOAc = 2/1). 
1H NMR (500 MHz, 
DMSO-d6) δ 8.78 (t, J = 5.2 Hz, 1H), 7.76 (d, J = 7.4 Hz, 
2H), 7.62 (t, J = 7.2 Hz, 1H), 7.48 (t, J = 7.5 Hz, 2H), 
7.18 – 7.08 (m, 3H), 6.86 – 6.72 (m, 2H), 4.29 (dd, J = 
15.1, 6.6 Hz, 1H), 3.96 (dd, J = 15.1, 4.8 Hz, 1H), 3.30 
(s, 1H), 1.72 (s, 3H), 1.43 (s, 9H). 13C NMR (126 MHz, 
DMSO-d6) δ 174.5, 165.9, 165.5, 138.5, 133.5, 132. 7, 
128. 7, 128.2, 127.9, 126.7, 82.5, 48.6, 44.1, 42.9, 27.7, 
13.4. HRMS (ESI) m/z: [M+H]+ Calcd for C23H27N2O4  




White solid, 52 mg, 20% yield, mp 94–95 °C. Silica gel 
TLC Rf = 0.42 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 9.66 (s, 1H), 6.91 (s, 2H), 6.83 (s, 
2H), 3.71 (s, 6H), 3.61 (s, 3H), 3.57 (s, 1H), 2.31 (s, 6H), 
2.18 (s, 3H), 1.67 (s, 3H), 1.40 (s, 9H). 13C NMR (126 
MHz, DMSO-d6) δ 175.9, 165.2, 164.3, 152.5, 138.9, 
135.9, 134.4, 133.9, 132.1, 128.8, 99.2, 82.5, 60.1, 55.8, 
48.7, 43.5, 27.6, 20.6, 20.0, 13.2. HRMS (ESI) m/z: 
[M+H]+ Calcd for C28H37N2O7  513.2601; Found 
513.2592. 
 




4{33}+5{33}): Yellow oil, 95 mg, 55% combined yield. 
Silica gel TLC Rf = 0.51 and Rf = 0.46 (diastereomers, 
hexane/EtOAc = 2/1). 1H NMR (500 MHz, DMSO-d6) 
major (trans) diastereomer: δ 7.79 (d, J = 7.2 Hz, 2H), 
7.54 (t, J = 7.5 Hz, 1H), 7.47 (t, J = 7.6 Hz, 2H), 7.40 (s, 
1H), 3.96 (dddd, J = 17.9, 10.8, 7.1, 3.8 Hz, 2H), 1.57 (s, 
3H), 1.54 (s, 3H), 1.26 (s, 9H), 1.00 (t, J = 7.1 Hz, 1H). 
minor (cis) diastereomer: δ 8.03 – 7.99 (m, 2H), 7.62 (t, J 
= 7.4 Hz, 1H), 7.51 (t, J = 7.8 Hz, 2H), 7.11 (s, 1H), 4.19 
– 4.04 (m, 2H), 1.39 (s, 3H), 1.37 (s, 3H), 1.23 (s, 9H), 
1.19 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) 
δ mixtures of diastereomers: 172.5, 172.4, 168.2, 167.2, 
166.8, 166.3, 134.7, 133.6, 133.1, 132.1, 128.7, 128.5, 
128.3, 127.7, 61.6, 61.6, 51.0, 50.9, 50.5, 49.8, 28.3, 
28.1, 16.0, 13.9, 13.9, 13.8. HRMS (ESI) m/z: [M+H]+ 
Calcd for C19H27N2O4  347.1971; Found 347.1971. 
(±)-Ethyl trans-1-benzoyl-3-(cyclohexylcarbamoyl)-
2,3-dimethylaziridine-2-carboxylate (rac-4{34}): 
White solid, 58 mg, 31% yield, mp 99–100 °C. Silica gel 
TLC Rf = 0.40 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.91 (d, J = 8.3 Hz, 1H), 7.77 (d, J = 
7.6 Hz, 2H), 7.54 (t, J = 7.3 Hz, 1H), 7.47 (t, J = 7.5 Hz, 
2H), 4.10 – 3.87 (m, 2H), 3.62 – 3.47 (m, 1H), 1.70 – 
1.61 (m, 4H), 1.55 (s, 3H), 1.54 (s, 4H), 1.32 – 1.16 (m, 
4H) 1.10 – 1.02 (m, 1H), 1.01 (t, J = 7.0 Hz, 3H). 13C 
NMR (126 MHz, DMSO-d6) δ 172.6, 167.3, 166.2, 
134.9, 132.1, 128.4, 127.7, 61.7, 48.3, 32.2, 25.2,24.9, 
24.9, 15.7, 13.8, 12.9. HRMS (ESI) m/z: [M+H]+ Calcd 
for C21H29N2O4  373.2127; Found 373.2129. 
 




(rac-4{35}+5{35}): Yellow oil, 84 mg, 41% combined 
yield. Alumina TLC Rf = 0.22 and Rf = 0.31 
(diastereomers, hexane/EtOH = 20/1). 1H NMR (500 
MHz, DMSO-d6) δ mixture of diastereomers: 8.73 (t, J = 
6.2 Hz, 1H), 8.55 (t, J = 6.1 Hz, 1H), 7.63 – 7.58 (m, 
1H), 7.57 (d, J = 7.7 Hz, 1H), 7.45 – 7.40 (m, 1H), 7.39 
(t, J = 7.8 Hz, 2H), 7.34 (s, 1H), 7.34 – 7.30 (m, 1H), 
7.30 – 7.21 (m, 8H), 7.21 – 7.07 (m, 3H), 4.31 – 4.26 (m, 
2H), 4.24 (d, J = 6.1 Hz, 2H), 3.99 (q, J = 7.1 Hz, 2H), 
3.92 (qt, J = 6.7, 3.3 Hz, 2H), 3.77 (s, 3H), 3.75 (s, 3H), 
1.58 (s, 3H), 1.53 (s, 3H), 1.42 (s, 3H), 1.37 (s, 3H). 13C 
NMR (126 MHz, DMSO-d6) δ mixtures of 
diastereomers: 172.4, 172.3, 168.1, 167.3, 167.3, 167.2, 
159.2, 159.1, 139.2, 139.2, 136.2, 135.1, 129.8, 129.7, 
128.3, 128.2, 127.6, 127.5, 126.9, 126.8, 120.6, 120.0, 
119.2, 118.0, 113.0, 112.5, 61.8, 61.3, 55.3, 55.3, 50.6, 
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49.7, 42.5, 42.5, 15.7, 14.1, 13.8, 13.8. HRMS (ESI) m/z: 




(rac-4{36}): Colorless oil, 36 mg, 17% yield. Silica gel 
TLC Rf = 0.66 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.69 – 7.56 (m, 3H), 7.46 (t, J = 7.6 
Hz, 1H), 7.39 – 7.33 (m, 2H), 7.32 – 7.21 (m, 5H), 4.03 – 
3.88 (m, 2H), 3.51 (d, J = 14.8 Hz, 1H), 2.81 (d, J = 14.9 
Hz, 1H), 1.49 (s, 3H), 1.30 (s, 9H), 0.95 (t, J = 6.9 Hz, 
3H). 13C NMR (126 MHz, DMSO-d6) δ 172.1, 166.6, 
166.3, 136.8, 134.5, 131.9, 129.5, 128.3, 128.1, 127.9, 
126.7, 61.5, 52.5, 52.4, 51.2, 35.2, 28.4, 14.5, 13.7. 
HRMS (ESI) m/z: [M+H]+ Calcd for C25H31N2O4  
423.2284; Found 423.2287. 
(±)-Ethyl cis-1-benzoyl-2-benzyl-3-(tert-
butylcarbamoyl)-3-methylaziridine-2-carboxylate 
(rac-5{36}): Colorless oil, 49 mg, 23% yield. Silica gel 
TLC Rf = 0.71 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.99 (d, J = 7.1 Hz, 2H), 7.63 (t, J = 
7.4 Hz, 1H), 7.51 (t, J = 7.9 Hz, 2H), 7.35 (d, J = 7.5 Hz, 
2H), 7.27 – 7.22 (m, 2H), 7.22 – 7.15 (m, 1H), 7.08 (s, 
1H), 3.88 – 3.74 (m, 2H), 3.28 – 3.10 (m, 2H), 1.42 (s, 
3H), 1.23 (d, J = 2.7 Hz, 9H), 0.82 (t, J = 7.2 Hz, 3H). 
13C NMR (126 MHz, DMSO-d6) δ 172.6, 166.8, 166.2, 
135.9, 133.8, 133.1, 129.5, 128.7, 128.4, 127.9, 126.6, 
61.0, 53.2, 50.9, 50.6, 33.9, 28.1, 14.8, 13.4. HRMS 
(ESI) m/z: [M+H]+ Calcd for C25H31N2O4  423.2284; 
Found 423.2287. 
(±)-trans-1-Benzoyl-N-(tert-butyl)-2,3-
diphenylaziridine-2-carboxamide (rac-4{37}): White 
solid, 139 mg, 70% yield, mp 126–127 °C. Silica gel 
TLC Rf = 0.90 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.86  (d, J = 7.7 Hz, 2H), 7.57 (t, J = 
7.5 Hz, 1H), 7.44 (t, J = 7.6 Hz, 2H), 7.35 – 7.26 (m, 
4H), 7.28 – 7.20 (m, 1H), 7.13 (bs, 5H), 5.90 (s, 1H), 
4.58 (s, 1H), 1.00 (s, 9H). 13C NMR (126 MHz, DMSO-
d6) δ 175.7, 164.3, 133.8, 132.9, 132.7, 132.0, 129.4, 
128.6, 128.5, 128.4, 128.1, 128.0, 127.7, 127.4, 57.6, 
51.4, 49.6, 27.9. HRMS (ESI) m/z: [M+H]+ Calcd for 
C26H27N2O2  399.2073; Found 399.2074. 
(±)-trans-1-Acetyl-N-(tert-butyl)-2,3-
diphenylaziridine-2-carboxamide (rac-4{38}): White 
solid, 102 mg, 61% yield, mp 116–117 °C. Silica gel 
TLC Rf = 0.77 (hexane/EtOAc = 3/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.30 – 7.22 (m, 3H), 7.22 – 7.18 (m, 
2H), 7.11 – 7.06 (m, 3H), 7.04 – 6.97 (m, 2H), 5.80 (s, 
1H), 4.35 (s, 1H), 2.13 (s, 3H), 1.18 (s, 9H). 13C NMR 
(126 MHz, DMSO-d6) δ 179.6, 165.1, 134.1, 132.1, 
129.4, 128.6, 128.5, 127.8, 127.5, 127.2, 57.0, 51.6, 48.3, 
28.1, 23.7. HRMS (ESI) m/z: [M+H]+ Calcd for 
C21H25N2O2  337.1916; Found 337.1916. 
(±)-trans-N-Cyclohexyl-2,3-diphenyl-1-(2,4,6-
trimethylbenzoyl)aziridine-2-carboxamide (rac-
4{39}): White solid, 65 mg, 28% yield, mp 135–136 °C. 
Silica gel TLC Rf = 0.94 (hexane/EtOAc = 2/1). 
1H NMR 
(500 MHz, DMSO-d6) δ 7.30 – 7.20 (m, 3H), 7.18 – 7.12 
(m, 2H), 7.02 (q, J = 6.9, 6.1 Hz, 3H), 6.91 – 6.84 (m, 
2H), 6.81 (s, 2H), 6.51 (d, J = 8.2 Hz, 1H), 4.54 (s, 1H), 
3.75 – 3.60 (m, 1H), 2.37 (s, 6H), 2.16 (s, 3H), 1.72 – 
1.40 (m, 5H), 1.30 – 1.09 (m, 5H). 13C NMR (126 MHz, 
DMSO-d6) δ 177.4, 164.6, 138.1, 134.4, 133.6, 133.4, 
132.3, 129.5, 128.4, 128.3, 127.7, 127.6, 127.1, 61.7, 
56.6, 48.8, 48.7, 31.7, 31.6, 25.0, 24.5, 20.6, 19.6. HRMS 




4{40}): White solid, 114 mg, 43% yield, mp 144–146 °C. 
Silica gel TLC Rf = 0.36 (hexane/EtOAc = 2/1). 
1H NMR 
(500 MHz, DMSO-d6) δ 8.80 (s, 1H), 7.33 – 7.19 (m, 
10H), 7.10 – 7.07 (m, 3H), 7.04 – 6.99 (m, 2H), 6.96 (s, 
2H), 4.66 (s, 1H), 3.95 (d, J = 16.0 Hz, 1H), 3.81 (d, J = 
16.1 Hz, 1H), 3.69 (s, 6H), 3.59 (s, 3H). 13C NMR (126 
MHz, DMSO-d6) δ 180.4, 165.0, 152.5, 134.7, 134.5, 
133.9, 133.7, 131.4, 129.8, 129.7, 128.5, 128.4, 128.2, 
127.7, 127.6, 127.4, 127.3, 126.6, 99.2, 60.1, 57.6, 55.9, 
49.4, 42.7. HRMS (ESI) m/z: [M+H]+ Calcd for 
C32H31N2O5 523.2233; Found 523.2227. 
(±)-trans-1-Benzoyl-2-benzyl-N-(tert-butyl)-3-
phenylaziridine-2-carboxamide (rac-4{41}): White 
solid, 138 mg, 67% yield, mp 146–147 °C. Silica gel 
TLC Rf = 0.82 (hexane/EtOAc = 3/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.74 (d, J = 7.5 Hz, 2H), 7.57 – 7.52 
(m, 1H), 7.51 (d, J = 7.5 Hz, 2H), 7.44 – 7.35 (m, 4H), 
7.33 (t, J = 7.1 Hz, 1H), 7.20 – 7.10 (m, 3H), 7.03 (d, J = 
7.0 Hz, 2H), 6.92 (s, 1H), 4.41 (s, 1H), 3.64 (d, J = 16.3 
Hz, 1H), 2.97 (d, J = 16.2 Hz, 1H), 0.87 (s, 9H). 13C 
NMR (126 MHz, DMSO-d6) δ 176.3, 164.3, 136.4, 
134.6, 133.3, 132.5, 128.6, 128.5, 128.4, 128.4, 128.2, 
128.0, 126. 5, 55.4, 51.0, 46.5, 32.0, 27.8. HRMS (ESI) 
m/z: [M+H]+ Calcd for C27H29N2O2  413.2229; Found 
413.2231. 
(±)-trans-1-Acetyl-2-benzyl-N-(tert-butyl)-3-
phenylaziridine-2-carboxamide (rac-4{42}): White 
solid, 109 mg, 62% yield, mp 151–152 °C. Silica gel 
TLC Rf = 0.57 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.52 (s, 1H), 7.45 – 7.37 (m, 4H), 
7.37 – 7.30 (m, 1H), 7.31 – 7.22 (m, 4H), 7.23 – 7.17 (m, 
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1H), 3.79 (s, 1H), 3.25 (d, J = 15.1 Hz, 1H), 2.44 (d, J = 
15.2 Hz, 1H), 1.65 (s, 3H), 1.22 (s, 9H). 13C NMR (126 
MHz, DMSO-d6) δ 180.2, 166.2, 137.2, 134.6, 129.3, 
128.3, 128.2, 127.9, 127.8, 126.7, 55.4, 51.4, 46.7, 32.6, 
28.3, 24.2. HRMS (ESI) m/z: [M+H]+ Calcd for 
C22H27N2O2  351.2073; Found 351.2074. 
(±)-trans-2-Benzyl-N-cyclohexyl-3-phenyl-1-(2,4,6-
trimethylbenzoyl)aziridine-2-carboxamide (rac-
4{43}): White solid, 96 mg, 40% yield, mp 132–133 °C. 
Silica gel TLC Rf = 0.75 (hexane/EtOAc = 2/1). 
1H NMR 
(500 MHz, DMSO-d6) δ 7.61 (d, J = 7.8 Hz, 1H), 7.39 – 
7.29 (m, 4H), 7.27 (t, J = 6.6 Hz, 1H), 7.12 – 7.02 (m, 
3H), 6.88 (d, J = 6.9 Hz, 2H), 6.81 (s, 2H), 4.42 (s, 1H), 
3.48 (d, J = 16.1 Hz, 1H), 3.46 – 3.37 (m, 1H), 2.76 (d, J 
= 16.1 Hz, 1H), 2.32 (s, 6H), 2.17 (s, 3H), 1.55 (d, J = 
13.1 Hz, 1H), 1.52 – 1.41 (m, 3H), 1.61 – 1.51 (m, 1H), 
1.52 – 1.41 (m, 3H), 1.39 – 1.29 (m, 1H), 1.20 – 1.05 (m, 
2H), 1.06 – 0.90 (m, 3H). 13C NMR (126 MHz, DMSO-
d6) δ 177.8, 164.2, 138.1, 136.3, 134.6, 134.2, 133.5, 
128.4, 128.4, 128.3, 128.0, 127.9, 127.6, 126.2, 54.1, 
48.5, 45.8, 32.1, 31.6, 25.2, 24.5, 24.4, 20.6, 19.9. HRMS 




(rac-4{44}): Yellow solid, 136 mg, 51% yield, mp 68–69 
°C. Silica gel TLC Rf = 0.73 (hexane/EtOAc = 1/1). 
1H 
NMR (500 MHz, DMSO-d6) δ 10.13 (s, 1H), 7.48 (d, J = 
7.7 Hz, 2H), 7.44 (t, J = 7.4 Hz, 2H), 7.42 – 7.34 (m, 
1H), 7.35 – 7.26 (m, 4H), 7.27 – 7.15 (m, 4H), 7.12 (d, J 
= 7.5 Hz, 2H), 7.07 (s, 2H), 4.02 (s, 1H), 3.75 (s, 6H), 
3.62 (s, 3H), 3.60 – 3.49 (m, 2H), 3.30 (s, 9H), 3.20 (d, J 
= 6.7 Hz, 2H). 13C NMR (126 MHz, DMSO-d6) δ 181.0, 
166.3, 152.7, 137.0, 135.4, 134.4, 134.2, 134.0, 129.4, 
129.3, 128.6, 128.4, 128.1, 128.0, 127.9, 127.0, 126.4, 
98.13, 6.14, 6.52, 55.8, 47.3, 43.2, 32.7. HRMS (ESI) 
m/z: [M+H]+ Calcd for C33H33N2O5  537.2389; Found 
537.2386. 






(4{45}): amorphous solid, 211 mg, 82% yield. Silica gel 
TLC Rf = 0.35 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 7.34, 7.32 (2 x s, 2 x 1 H), 7.12, 7.09 
(2 x d, 2 x 1 H, J = 8.3 Hz), 4.22 – 4.09 (m, 2 x 2H), 3.88 
– 3.70 (m, 2 x 1H), 3.27 (s, 2 x 1H), 2.39 – 2.25 (m, 2 x 
1H), 2.23 – 2.08 (m, 2 x 1H), 1.91 – 1.68 (m, 2 x 2H), 
1.53, 1.52 (2 x s, 2 x 3H), 1.41 – 1.31 (m, 2 x 18H), 1.29 
– 1.24 (m, 2 x 9H), 1.21 (t, J = 6.8 Hz, 2 x 3H). 13C NMR 
(126 MHz, DMSO-d6) δ 180.3, 180.2, 171.4, 171.3, 
166.4, 166.4, 165.5, 165.5, 155.6, 155.5, 80.4, 80.4, 78.1, 
61.4, 53.9, 53.6, 51.7, 51.6, 48.4, 48.4, 42.7, 42.6, 33.4, 
33.0, 28.2, 28.2, 27.6, 26.0, 25.9, 4.1, 13.6, 13.6. HRMS 
(ESI) m/z: [M+H]+ Calcd for C25H44N3O8  514.3128; 
Found 514.3125. 






(rac-4{46}): amorphous solid, 287 mg, 70% yield. Silica 
gel TLC Rf = 0.57 and 0.66 (two diastereomers, 
hexane/EtOAc = 1/1). 1H NMR (500 MHz, DMSO-d6) δ 
8.55 (s, 1H), 8.54 (s, 1H), 7.88 (d, 2 x 2H, J = 7.5 Hz), 
7.78 – 7.72 (m, 1H), 7.74 – 7.67 (m, 2 x 2H), 7.49 – 7.42 
(m, 1H), 7.40 (t, 2 x 2H, J = 7.5 Hz), 7.35 – 7.26 (m, 2 x 
2H), 7.27 – 7.20 (m, 13H), 7.20 – 7.13 (m, 17H), 7.12 (s, 
1H), 4.36 – 4.27 (m, 2H), 4.27 – 4.18 (m, 4H), 4.17 – 
4.01 (m, 6H), 3.19 (s, 1H), 2.36 – 2.13 (m, 4H), 2.05 – 
1.88 (m, 4H), 1.74 – 1.62 (m, 2H), 1.50 – 1.44 (m, 6H), 
1.24 – 1.19 (m, 18H), 1.19 – 1.12 (m, 6H). 13C NMR 
(126 MHz, DMSO-d6) δ 179.7, 171.4, 166.2, 166.0, 
165.5, 165.5, 156.0, 155.8, 145.0, 144.9, 143.9, 143.8, 
140.7, 128.6, 127.7, 127.4, 127.1, 126.3, 125.3, 125.3, 
120.2, 69.2, 67.3, 65.9, 61.7, 61.3, 55.3, 55.0, 51.6, 46.7, 
32.6, 32.4, 28.2, 28.2, 27.5, 22.8, 14.0, 13.3, 13.2. HRMS 





(rac-4{47}): White solid, 150 mg, 75% yield, mp 99–101 
°C. Silica gel TLC Rf = 0.57 (hexane/EtOAc = 1/1). 
1H 
NMR (500 MHz, DMSO-d6) δ 7.35 (s, 1H), 6.66 (t, J = 
6.0 Hz, 1H), 4.22 – 4.08 (m, 2H), 3.27 (s, 1H), 3.16 – 
3.07 (m, 3H), 2.47 – 2.38 (m, 1H), 2.27 – 2.19 (m, 1H), 
1.53 (s, 3H), 1.34 (s, 9H), 1.26 (s, 9H), 1.23 – 1.20 (m, 
3H). 13C NMR (126 MHz, DMSO-d6) δ 179.2, 166.4, 
165.6, 155.4, 77.6, 61.4, 51.7, 48.4, 42.7, 36.9, 35.9, 
28.2, 28.2, 14.1, 13.6. HRMS (ESI) m/z: [M+H]+ Calcd 
for C19H34N3O6  400.2448; Found 400.2448. 
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methylaziridine-2-carboxylate (4{48}): amorphous 
solid, 148 mg, 64% yield. Silica gel TLC Rf = 0.81 
(hexane/EtOAc = 1/1). 1H NMR (500 MHz, DMSO-d6) δ 
7.82 (d, J = 9.7 Hz, 1H), 7.41 (d, J = 9.4 Hz, 1H), 7.37 – 
7.26 (2 x m, 2 x 5H), 7.24 (s, 1H), 7.19 (s, 1H), 5.23 (d, J 
= 9.8 Hz, 1H), 5.10 (d, J = 8.7 Hz, 1H), 4.24 – 3.95 (2 x 
m, 2 x 2H), 3.22 (s, 1H), 3.12 (s, 1H), 1.37 (s, 9H), 1.32 
(s, 9H), 1.30 (s, 9H), 1.28 (s, 9H), 1.32 – 1.25 (m, 2 x 
3H). 13C NMR (126 MHz, DMSO-d6) δ 178.9, 178.9, 
166.0, 166.0, 165.7, 165.6, 154.8, 154.7, 138.8, 138.5, 
128.3, 128.1, 128.0, 127.7, 127.4, 127.3, 78.5, 78.3, 61.4, 
59.8, 58.9, 51.8, 51.7, 49.5, 49.3, 43.0, 42.8, 28.3, 28.2, 
28.2, 28.1, 14.0, 13.2, 12.9. HRMS (ESI) m/z: [M+H]+  
Calcd for C24H36N3O6  462.2604; Found 462.2608. 
General procedure and characterization data for 
racemic N-acylaziridine dicarboxamides 6–11: To a 
solution of aziridine ester 4 (0.3 mmol, 1 equiv.) in 
cooled THF (1.5 mL, 0 °C) was added 1 M NaOH 
solution (0.35 mmol, 1.16 equiv.) dropwise. Then the 
mixture was warmed up to room temperature and stirred 
for 12 h. After the ester hydrolysis was completed, the 
organic solvent was removed under reduced pressure and 
the resulting residue was used immediately for the next 
step without any further purification. 
To a solution of the above compound in DMF (6 mL) 
were added N-Ethyl-N′-(3-
dimethylaminopropyl)carbodiimide hydrochloride (0.35 
mmol, 1.16 equiv), amine (0.3 mmol, 1 equiv) and 1-
Hydroxybenzotriazole (0.41 mmol, 1.38 equiv). The 
reaction mixture was stirred for 12 h at room 
temperature, then extracted with EtOAc (2 x 10 mL). The 
combined organic layers were dried over Na2SO4 and the 
solvent was evaporated under reduced pressure. The 
crude material was purified by column chromatography 






methylaziridine-2,3-dicarboxamide (rac-6): White 
solid, 76 mg, 74% yield, mp 155–157 °C. Silica gel TLC 
Rf = 0.33 (toluene/MeCN = 2/1). 
1H NMR (500 MHz, 
CDCl3-d1) δ 7.79 (d, J = 7.1 Hz, 2H), 7.48 (t, J = 7.4 Hz, 
1H), 7.39 (t, J = 7.6 Hz, 2H), 6.53 (s, 1H), 5.73 (s, 1H), 
3.70 (s, 1H), 2.83 – 2.69 (m, 1H), 1.65 (s, 3H), 1.01 (s, 
9H), 0.87 – 0.74 (m, 2H), 0.65 – 0.44 (m, 2H). 13C NMR 
(126 MHz, CDCl3-d1) δ 175.9, 167.0, 164.2, 133.5, 
132.1, 127.9, 127.8, 51.6, 48.6, 45.1, 27.6, 22.0, 14.1, 
6.1. HRMS (ESI) m/z: [M+H]+ Calcd for C19H26N3O3  






2-yn-1-yl)aziridine-2,3-dicarboxamide (rac-7): White 
solid, 87 mg, 85% yield, mp 159–160 °C. Silica gel TLC 
Rf = 0.45 (toluene/MeCN = 2/1). 
1H NMR (500 MHz, 
DMSO-d6) δ
  8.80 (t, J = 5.7 Hz, 1H), 7.73 (d, J = 7.1 Hz, 
2H), 7.54 (t, J = 7.4 Hz, 1H), 7.45 (t, J = 7.6 Hz, 2H), 
7.09 (s, 1H), 3.96 – 3.75 (m, 2H), 3.43 (s, 1H), 3.11 (t, J 
= 2.5 Hz, 1H), 1.67 (s, 3H), 0.96 (s, 9H). 13C NMR (126 
MHz, DMSO-d6) δ 175.2, 165.4, 165.1, 133.8, 132.3, 
128.4, 127.9, 80.8, 73.0, 51.3, 49.4, 44.2, 28.1, 27.8, 
13.5. HRMS (ESI) m/z: [M+H]+ Calcd for C19H24N3O3  
342.1818; Found 342.1818. 
(±)-trans-1-Benzoyl-N2-(tert-butyl)-2-methyl-N3-
phenylaziridine-2,3-dicarboxamide (rac-8): White 
solid, 108 mg, 95% yield, mp 188–190 °C. Silica gel 
TLC Rf = 0.28 (hexane/EtOAc = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 10.52 (s, 1H), 7.79 (d, J = 7.5 Hz, 
2H), 7.65 (d, J = 7.9 Hz, 2H), 7.57 (t, J = 7.4 Hz, 1H), 
7.49 (t, J = 7.5 Hz, 2H), 7.34 (t, J = 7.9 Hz, 2H), 7.17 (s, 
1H), 7.10 (t, J = 7.4 Hz, 1H), 3.71 (s, 1H), 1.77 (s, 3H), 
1.02 (s, 9H). 13C NMR (126 MHz, DMSO-d6) δ 175.7, 
165.7, 164.5, 139.0, 134.3, 132.8, 129.3, 128.9, 128.4, 
124.3, 120.0, 51.81, 50.1, 45.2, 28.3, 13.7. HRMS (ESI) 
m/z: [M+H]+ Calcd for C22H26N3O3 380.1974; Found 
380.1975. 
(±)-trans-1-Benzoyl-N2-cyclohexyl-N3-cyclopropyl-2-
methylaziridine-2,3-dicarboxamide (rac-9): White 
solid, 102 mg, 92% yield, mp 193–195 °C. Silica gel 
TLC Rf = 0.31 (toluene/MeCN = 2/1). 
1H NMR (500 
MHz, DMSO-d6) δ 8.41 (d, J = 3.2 Hz, 1H), 7.74 (d, J = 
7.7 Hz, 1H), 7.70 (d, J = 7.3 Hz, 2H), 7.53 (t, J = 7.1 Hz, 
1H), 7.44 (t, J = 7.3 Hz, 2H), 3.38 (s, 1H), 3.28 – 3.17 
(m, 1H), 2.74 – 2.63 (m, 1H), 1.63 (s, 3H), 1.61 – 1.57 
(m, 1H), 1.58 – 1.51 (m, 1H), 1.51 – 1.42 (m, 2H), 1.27 – 
0.84 (m, 6H), 0.61 (d, J = 6.1 Hz, 2H), 0.52 – 0.38 (m, 
2H). 13C NMR (126 MHz, DMSO-d6) δ 175.1, 166.4, 
165.1, 133.9, 132.2, 128.4, 127.9, 48.9, 44.5, 31.6, 25.1, 
24.9, 24.7, 22.5, 13.2, 5.7, 5.6. HRMS (ESI) m/z: 
[M+H]+ Calcd for C21H28N3O3  370.2131; Found 
370.2130. 
(±)-trans-1-Benzoyl-N2-(tert-butyl)-N3-cyclobutyl-2-
methylaziridine-2,3-dicarboxamide (rac-10): White 
solid, 81 mg, 68% yield, mp 209–211 °C. Silica gel TLC 
Rf = 0.46 (toluene/MeCN = 2/1). 
1H NMR (500 MHz, 
CDCl3-d1) δ 7.83 (d, J = 7.7 Hz, 2H), 7.50 (t, J = 7.3 Hz, 
1H), 7.41 (t, J = 7.6 Hz, 2H), 6.54 (d, J = 7.9 Hz, 1H), 
5.80 (d, J = 7.5 Hz, 1H), 4.49 – 4.34 (m, 1H), 3.70 (s, 
1H), 3.54 – 3.38 (m, 1H), 2.44 – 2.23 (m, 2H), 2.02 – 
1.84 (m, 2H), 1.80 – 1.69 (m, 3H), 1.68 (s, 3H), 1.62 (d, J 
= 13.3 Hz, 1H), 1.56 – 1.45 (m, 2H), 1.39 – 1.30 (m, 1H), 
1.29 – 0.98 (m, 4H), 0.85 – 0.71 (m, 1H). 13C NMR (126 
MHz, CDCl3-d1) δ 175.6, 164.5, 164.4, 133.4, 132.1, 
128.0, 127.8, 48.7, 48.3, 45.3, 44.1, 32.0, 32.0, 30.7, 
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30.6, 24.9, 24.2, 24.1, 14.7, 13.9. HRMS (ESI) m/z: 








dicarboxamide (rac-11): White solid, 104 mg, 87% 
yield, mp 147–148 °C. Silica gel TLC Rf = 0.56 
(toluene/MeCN = 2/1). 1H NMR (500 MHz, CDCl3-d1) δ 
7.80 (d, J = 8.0 Hz, 2H), 7.49 (t, J = 7.2 Hz, 1H), 7.39 (t, 
J = 7.5 Hz, 2H), 6.48 (s, 1H), 5.83 (s, 1H), 3.67 (s, 1H), 
2.81 – 2.67 (m, 1H), 1.64 (s, 3H), 1.42 (q, J = 15.0 Hz, 
2H), 1.14 (s, 3H), 1.00 (s, 3H), 0.87 (s, 9H), 0.84 – 0.77 
(m, 2H), 0.64 – 0.47 (m, 2H). 13C NMR (126 MHz, 
CDCl3-d1) δ 175.9, 167.0, 163.9, 133.7, 132.1, 128.0, 
127.8, 55.7, 52.1, 48.8, 45.0, 31.1, 31.0, 27.7, 27.1, 22.0, 
14.1, 6.1. HRMS (ESI) m/z: [M+H]+ Calcd for 
C23H34N3O3  400.2600; Found 400.2601. 
(±)-trans-Ethyl 3-(tert-butylcarbamoyl)-3-
methylaziridine-2-carboxylate (rac-12):13a To a 
solution of ethyl 3-(tert-butylcarbamoyl)-3-methyl-1-
(2,2,2-trifluoroacetyl)aziridine-2-carboxylate 4{10} (0.6 
mmol, 200 mg) in cooled EtOH (0.8 mL, 0 °C) was 
added sodium borohydride (0.9 mmol, 35 mg, 1.5 equiv). 
The mixture was warmed up to room temperature and 
stirred for 2 h, then quenched with water (10 
mL) and extracted with EtOAc (2 x 15 mL). The 
combined organic extracts were dried over Na2SO4 and 
the solvent was evaporated under reduced pressure. The 
crude material was purified by column chromatography 
(toluene/MeCN : 8/1) to afford the desired product as 
white solid (126 mg, 92% yield), mp 60–62 °C. Silica gel 
TLC Rf = 0.56 (toluene/MeCN = 3/1). 
1H NMR (500 
MHz, CDCl3-d1) δ 6.62 (s, 1H), 4.24 (qd, J = 7.1, 1.5 Hz, 
2H), 2.52 (d, J = 8.0 Hz, 1H), 1.52 (s, 3H), 1.38 (s, 1H), 
1.31 (d, J = 5.3 Hz, 12H). 13C NMR (126 MHz, CDCl3-
d1) δ 169.6, 169.2, 62.0, 50.5, 42.7, 41.3, 28.5, 14.2, 13.0. 
HRMS (ESI) m/z: [M+H]+ Calcd for C11H21N2O3  
229.1552; Found 229.1550. 
General procedure and characterization data for 
racemic oxazolines 13–16: 
Method A
26
: To a solution of ethyl 1-benzoyl-3-(tert-
butylcarbamoyl)-3-methylaziridine-2-carboxylate 4{1} 
(trans) or 5{1} (cis) (0.5 mmol, 166 mg) in DMF (8 mL) 
was added sodium iodide (1.25 mmol, 187 mg, 2.5 equiv) 
and the mixture was stirred for 12 h at 100 °C. Upon 
completion of the reaction as indicated by TLC, water 
(10 mL) was added and extracted with EtOAc (2 x 15 
mL). The combined extracts were dried over anhydrous 
Na2SO4. The solvents were removed in vacuo, and the 
residue was purified by column chromatography 
(hexane/EtOAc: 6/1) to give the corresponding oxazoline 
13 and 14. 
(±)-Ethyl trans-4-(tert-butylcarbamoyl)-4-methyl-2-
phenyl-4,5-dihydrooxazole-5-carboxylate (rac-13): 
White solid, 130 mg, 78% yield, mp 91–92 °C. Silica gel 
TLC Rf = 0.53 (hexane/EtOAc = 3/1). 
1H NMR (500 
MHz, DMSO-d6) δ δ 7.93 (d, J = 7.8 Hz, 2H), 7.61 (t, J = 
7.4 Hz, 1H), 7.51 (t, J = 7.6 Hz, 2H), 6.72 (s, 1H), 5.40 
(s, 1H), 4.25 – 4.11 (m, 2H), 1.35 (s, 3H), 1.26 (s, 9H), 
1.24 – 1.18 (m, 3H). 13C NMR (126 MHz, DMSO-d6) δ 
171.6, 168.2, 162.3, 132.5, 128.9, 128.3, 126.2, 81.0, 
77.8, 61.3, 50.6, 28.3, 22.0, 14.1. HRMS (ESI) m/z: 




Colorless oil, 133 mg, 80% yield. Silica gel TLC Rf = 
0.60 (hexane/EtOAc = 3/1).  1H NMR (500 MHz, 
DMSO-d6) δ 7.92 (d, J = 7.7 Hz, 2H), 7.60 (t, J = 7.3 Hz, 
1H), 7.51 (t, J = 7.6 Hz, 2H), 6.71 (s, 1H), 4.92 (s, 1H), 
4.13 – 3.98 (m, 2H), 1.50 (s, 3H), 1.23 (s, 9H), 1.17 (t, J 
= 7.1 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 170.6, 
168.6, 162.6, 132.5, 128.9, 128.3, 126.1, 84.2, 78.9, 61.0, 
50.3, 28.2, 27.2, 14.0. HRMS (ESI) m/z: [M+H]+ Calcd 
for C18H25N2O4  333.1814; Found 333.1815. 
Method B
20: To a solution of ethyl 1-benzoyl-3-(tert-
butylcarbamoyl)-3-methylaziridine-2-carboxylate 4{1} 
(trans) or 5{1} (cis) (0.5 mmol, 166 mg) in DCM (10 
mL) was added boron trifluoride dihydrate (1.5 mmol, 95 
µL, 3 equiv) and the mixture was stirred for 6 h at room 
temperature. Upon completion of the reaction as 
indicated by TLC, saturated aqueous NaHCO3 (15 mL) 
was added and extracted with DCM (2 x 15 mL). The 
combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. The crude material 
was purified by column chromatography (hexane/EtOAc: 
4/1) to give the corresponding oxazoline 15 and 16. 
(±)-Ethyl trans-5-(tert-butylcarbamoyl)-5-methyl-2-
phenyl-4,5-dihydrooxazole-4-carboxylate (rac-15): 
White solid, 141 mg, 85% yield, mp 98–100 °C. Silica 
gel TLC Rf = 0.38 (hexane/EtOAc = 3/1).  
1H NMR (500 
MHz, DMSO-d6) δ 8.00 (d, J = 7.5 Hz, 2H), 7.60 (t, J = 
7.4 Hz, 1H), 7.51 (t, J = 7.6 Hz, 2H), 7.25 (s, 1H), 5.05 
(s, 1H), 4.17 (q, J = 7.1 Hz, 2H), 1.48 (s, 3H), 1.25 (s, 
9H), 1.21 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, 
DMSO-d6) δ 170.7, 169.0, 163.7, 132.3, 128.8, 128.3, 
126.6, 87.0, 73.6, 61.0, 50.9, 28.2, 19.6, 14.1. HRMS 
(ESI) m/z: [M+H]+ Calcd for C18H25N2O4  333.1814; 
Found 333.1814. 
Page 16 of 19
ACS Paragon Plus Environment































































Colorless oil, 120 mg, 72% yield. Silica gel TLC Rf = 
0.44 (hexane/EtOAc = 3/1).  1H NMR (500 MHz, 
DMSO-d6) δ 8.00 (d, J = 7.6 Hz, 2H), 7.60 (t, J = 7.5 Hz, 
1H), 7.50 (t, J = 7.6 Hz, 2H), 7.02 (s, 1H), 4.61 (s, 1H), 
4.11 – 4.02 (m, 1H), 4.01 – 3.94 (m, 1H), 1.55 (s, 3H), 
1.26 (s, 9H), 1.16 (t, J = 7.1 Hz, 3H). 13C NMR (126 
MHz, DMSO-d6) δ 169.5, 169.4, 163.7, 132.3, 128.7, 
128.4, 126.6, 88.1, 77.0, 60.8, 50.7, 28.2, 25.6, 13.9. 
HRMS (ESI) m/z: [M+H]+ Calced for C18H25N2O4  
333.1814; Found 333.1817. 
Ethyl 2-benzamido-4-(tert-butylamino)-3-hydroxy-3-
methyl-4-oxobutanoate (17): A solution of (±)-ethyl 
trans-1-benzoyl-3-(tert-butylcarbamoyl)-3-
methylaziridine-2-carboxylate rac-4{1} (0.3 mmol, 99.7 
mg), Sc(OTf)3 (25 mol%, 37 mg) and water (10 equiv., 
56 µL) in acetonitrile (1 mL) was stirred for 24 h at room 
temperature. Then reaction mixture was extracted with 
water (5 mL) and EtOAc (2 x 5 mL), dried over 
anhydrous Na2SO4 and concentrated in vacuo. The crude 
material was purified by column chromatography 
(hexane/EtOAc: 4/1) to give product 17 as white solid, 75 
mg, 71% yield, mp 141–143 °C. Silica gel TLC Rf = 0.55 
(hexane/EtOAc = 1/1). 1H NMR (500 MHz, CDCl3-d1) δ 
7.93 (d, J = 9.5 Hz, 1H), 7.86 (d, J = 7.6 Hz, 2H), 7.53 (t, 
J = 7.3 Hz, 1H), 7.46 (t, J = 7.5 Hz, 2H), 6.69 (s, 1H), 
5.00 (d, J = 9.4 Hz, 1H), 4.96 (s, 1H), 4.29 – 4.14 (m, 
2H), 1.47 (s, 3H), 1.34 (s, 9H), 1.25 (t, J = 7.2 Hz, 3H). 
13C NMR (126 MHz, CDCl3-d1) δ 174.7, 172.1, 166.8, 
133.2, 131.4, 128.2, 126.8, 75.5, 61.9, 57.8, 50.7, 28.1, 
23.8, 13.6. HRMS (ESI) m/z: [M+H]+ Calcd for 
C18H27N2O5 351.1920; Found 351.1922. 
Associated content 
Supporting Information: 1H NMR and 13C NMR spectra 
for new compounds, 2D NMR spectra, LC/MS 
chromatograms. 
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